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There is an association between schizophrenia and violence, although the specific drivers for 
this link remain unclear.  This study aimed to explore the relationships between childhood 
adversity, conduct disorder, substance misuse and violence among men with schizophrenia.  
It has been suggested that there may be different pathways to violence in schizophrenia, one 
primarily linked with pre-morbid conduct disorder, so patients were specifically grouped on the 
basis of pre-morbid conduct disorder.   
 
Methods 
Ninety-three male participants were recruited for the study, fifty-four with schizophrenia and 
thirty-nine healthy controls.  Participants underwent a range of clinical assessments, including 
symptoms of conduct disorder, exposure to childhood adversities and history of substance use 
disorders.  Adult propensity to violence was measured using the Gunn Robertson Violence 




The Gunn Robertson Violence Scale has good validity in this population.  Conduct disorder 
was associated with an increased propensity to violence.  Exposure to domestic violence 
during childhood and the cumulative number of childhood adversities were both associated 
with adult propensity to violence and attenuation of the association with cumulative adversities 
suggested that conduct disorder may be a mediator of the relationship.  Patients with pre-
morbid conduct disorder began using alcohol and cannabis earlier and more frequently, and 
had higher rates of lifetime substance use disorders which were associated with an increased 
propensity to violence.  An increase in grey matter volume in the caudate was correlated with 







Conduct disorder, substance use disorders, childhood adversity, schizophrenia and violence 
are all associated with each other.  Hence there is a complex interplay of factors, with their 
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Chapter 1 Introduction to Schizophrenia 
 
1.1 Abstract 
In this chapter the diagnostic features of schizophrenia and its epidemiology and aetiology are 
described.  The clinical management of the illness is also outlined. 
 
1.2 Background 
Schizophrenia is a psychiatric disorder that falls within the category of psychotic illnesses.  It is 
characterized by the presence of certain symptoms and signs, in particular delusions, 
disorganization of thinking and hallucinations.  The illness can be differentiated from other 
psychotic illnesses, such as psychotic depression and delusional disorder, by careful 
consideration of the diagnostic criteria (see 1.3.5).  The presence of hallucinations and 
delusions, in the absence of prominent mood symptoms or organic cause, is often 
conceptualized as the core of schizophrenia.  Due to the pervasiveness of the deficits 
associated with schizophrenia and its often chronic course, it is among the top ten leading 
causes of disease-related disability in the world (Tandon et al., 2008b). 
 
The term schizophrenia was derived from the early observation that the illness is typified by a 
splitting of the mind (Bleuler, 1911), from the Greek words ‘schizo’ (split) and ‘phren’ (mind).  
The fundamental symptoms of schizophrenia proposed by Bleuler, referred to as Bleuler’s four 
As, were Ambivalence, Autism, Affective incongruity and loosening of Associations.  His view 
of schizophrenia had a significant impact on clinical practice, particularly in the United States 
of America.  In Europe, the work of Schneider was influential; he described first rank 
symptoms (see figure 1-1), arguing that the presence of one of these symptoms, in the 
absence of organic disease, was positive evidence for schizophrenia (Oyebode, 2008).  
Indeed the presence of first rank symptoms alone (without considering other diagnostic 
criteria) correctly identifies people with schizophrenia 75% to 95% of the time (Soares-Weiser 




Auditory hallucinations in the following form: 
 Two or more voices discussing the patient or arguing about them  
 Voices commenting on their thoughts or behaviour  
 Audible thoughts 
 
Passivity experiences 
 Somatic passivity (external influence on the body) 
 Passivity of affect (‘made’ feelings) 
 Passivity of impulse (‘made’ drives) 
 Passivity of volition (‘made’ volitional acts) 
 
Passivity of thought 
 Thought withdrawal 
 Thought insertion 
 Thought broadcast 
 
Delusional perception  (a normal perception which the patient falsely believes has special 
meaning for them)  
 




1.3.1 Positive symptoms 
Positive psychotic symptoms are principally thought disorder, delusions and hallucinations.  
Disorders in the form of thinking relate to abnormalities in the associations between thoughts 
and are a key diagnostic feature of schizophrenia.  Features of formal thought disorder 
include: derailment (one thought slides onto another); substitution (a major thought is 
substituted by a subsidiary one); omission (omission of a thought or part of it); fusion (different 
elements of thought are interwoven) but can be difficult to distinguish from one another 




Delusions are a ‘false, unshakeable belief that is out of keeping with the patient’s social and 
cultural background’ (Casey and Kelly, 2007).  Although this traditional definition of a delusion 
includes that the belief is false, this does not necessarily have to be the case.  For example, a 
patient may have delusions of jealousy, yet it could be true that their partner is having an 
affair; it is the abnormal thinking that has led to the belief and the fact that it is not amenable to 
reason that make it a delusional belief.  Delusions are judgements that are held with 
extraordinary conviction and subjective certainty and are impervious to compelling 
counterargument (Oyebode, 2008).  Amongst the most common types of delusion in 
schizophrenia are delusions of persecution, delusions of reference, grandiose delusions, 
religious delusions and delusions of control.   Delusions can also occur in severe affective 
illnesses (when the delusions will often be mood congruent, for example grandiose delusions 
in mania), or in delusional disorder (when the delusions would not be bizarre and no other 
symptoms of schizophrenia are present). 
 
Hallucinations are ‘a false perception which is not a sensory distortion or misinterpretation, but 
which occurs at the same time as real perceptions’ (Casey and Kelly, 2007).  For the person 
experiencing an hallucination, they are a normal sensory experience, but one quality of a 
normal object perception is likely to be absent – ‘publicness’, often the person hallucinating 
does not believe that others can share their experience (and may give a delusional 
explanation for this) (Oyebode, 2008).  Hallucinations can occur in any of the five senses and 
also with somatic sensation.  Certain types of auditory hallucinations are of particular 
diagnostic significance for schizophrenia (see figure 1-1).  Hallucinations may be intimately 
linked to delusional beliefs, for example a patient with the gustatory hallucination of a metallic 
taste to their food may have a delusional explanation of being poisoned. 
 
1.3.2 Negative symptoms 
Negative symptoms represent a withdrawal or lack of function and include emotional apathy, 
slowness of thought and movement, lack of motivation, poverty of speech and social 
withdrawal.  Negative symptoms are harder to recognise than positive symptoms and can be 
mistaken for depression and other conditions.  The presence of negative symptoms can be a 
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considerable barrier to rehabilitation.  Prognosis, and the patient’s and their carers’ quality of 
life, is probably affected to a greater extent by negative, rather than positive, symptoms 
(Oyebode, 2008).   
 
1.3.3 Cognitive deficits 
Whilst not forming part of current diagnostic criteria, cognitive deficits in schizophrenia have 
been extensively documented.  These deficits are present prior to the first episode of 
psychosis and particularly include memory, attention and executive functioning impairments, 
and may be related to poor prognosis (Gopal and Variend, 2005).   Some patients may report 
changes in their memory but often cognitive deficits are only detected when specific tests are 
performed.  Memory deficits are associated with greater severity and chronicity of illness, with 
the presence of negative symptoms and with formal thought disorder (Oyebode, 2008).  
 
1.3.4 Clinical subtypes 
Schizophrenia has been classified on the basis of symptoms into different subtypes, including 
paranoid schizophrenia, hebephrenic (or disorganized) schizophrenia and catatonic 
schizophrenia.  Paranoid schizophrenia is characterized by delusions and hallucinations, as 
described in 1.3.1 and 1.3.2.  In hebephrenic schizophrenia there is disorganized speech and 
behaviour and inappropriate affect.  The psychomotor disturbance of catatonic schizophrenia 
includes symptoms such as posturing and mutism.  Paranoid schizophrenia is the most 
common subtype (Sartorius et al., 1974) and is the focus of this thesis.  These subtypes are 
no longer used in the most recent edition of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM), (see 1.3.5.2), one of the two major classification manuals. 
 
1.3.5 Operationalized diagnosis 
1.3.5.1 ICD-10 
In clinical practice in the United Kingdom, and much of Europe, the World Health 
Organization’s International Classification of Diseases and Related Health Problems 10
th
 
revision (ICD-10), is utilized to structure  the diagnosis of schizophrenia (World Health 
Organization, 1992).  The diagnostic criteria for paranoid schizophrenia in ICD-10 require the 
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presence of persistent delusions, or thought echo, insertion, withdrawal or broadcast, or 
hallucinatory voices giving a running commentary on their behaviour, or discussing them 
between themselves for a month; or at least two of: persistent hallucinations, incoherent 
speech, catatonia or negative symptoms (World Health Organization, 1992). 
 
1.3.5.2 DSM-IV and DSM-5 
The American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders 
(DSM) is the operationalized criteria used in United States of America and many research 
studies worldwide.  At the time of commencing the study described in this thesis, the fourth 
edition, DSM-IV (American Psychiatric Association, 2000) was current and are the diagnostic 
criteria utilized in this research.  This has recently been updated to DSM-5 (American 
Psychiatric Association, 2013).  The diagnostic criteria for paranoid schizophrenia in DSM-IV 
include the presence for one month of one of: bizarre delusions or running commentary or two 
voices arguing; or two of: other delusions, hallucinations, disorganized speech, catatonic 
behaviour, negative symptoms; and deterioration in functioning over at least six 
months(American Psychiatric Association, 2000).  They also require that other medical, mood, 
psychotic and substance use disorders are ruled out.   
 
DSM-5 raises the symptom threshold for a diagnosis of schizophrenia, requiring that an 
individual exhibit at least two of the specified symptoms (when previously one symptom of 
certain delusions or hallucinations was possible in DSM-IV).  The other diagnostic criteria for 
schizophrenia in DSM-5 are largely similar to DSM-IV.  However, DSM-5 diagnostic criteria no 
longer identify subtypes, as they were considered not to be helpful clinically due to patients’ 
changing and overlapping symptoms, which decreased their validity. 
 
1.4 Epidemiology 
Transient, mild psychotic experiences can occur in healthy people (incidence of 2%) and are 
not associated with the functional impairment that would constitute illness (Hanssen et al., 
2005). This has led to the conclusion that schizophrenia reflects a quantitative rather than 





Schizophrenia typically presents in late adolescence or early adulthood.  It is more common in 
men than women, with a male:female relative risk of approximately 1.4 (Tandon et al., 2008a).  
The age of onset is earlier in males and male gender is also associated with a poorer 
prognosis (Tandon et al., 2009).   
 
Schizophrenia has a lifetime risk of around 1% (Schizophrenia Working Group of the 
Psychiatric Genomics Consortium, 2014).  The annual incidence of schizophrenia averages 15 
per 100,000 and the point prevalence is 4.5 per population of 1000 (Tandon et al., 2008a).  
The prevalence is relatively high with respect to the incidence due to the onset in early adult 





It has been recognised for many years that schizophrenia runs in families and now family and 
twin studies have demonstrated a strong genetic component (Lichtenstein et al., 2009, 
Sullivan et al., 2003), with heritability of between 64% and 81% respectively.  Owing to this 
high heritability, there were many efforts to discover the causative genetic factors, and prior to 
the technological advances that heralded the genome-wide association study (GWAS) era, 
candidate gene studies were the focus.  This strategy investigated candidate genes such as 
catechol-O-methyltransferase (COMT) and brain-derived neurotrophic factor (BDNF) but 
initially promising results were not consistently replicated.  Current genomic evidence is 
inconsistent with an association with a particular gene and the effects originally reported in 
candidate gene studies are now considered very unlikely to be true (Farrell et al., 2015).  
However, it has recently been described that ‘after two decades of frustration, genetic studies 
of schizophrenia have entered an era of spectacular success’ (Kavanagh et al., 2015).  
Technological advances have enabled analyses of genetic variation on a genome-wide scale, 
both for common alleles through genome-wide association studies (GWAS), as well as rare 




1.5.1.2 Common genetic variation 
Schizophrenia is highly polygenic, with the suggestion that one third of the genetic liability 
could be explained by more than a thousand individual susceptibility single-nucleotide 
polymorphisms (SNPs) (Purcell et al., 2009).  Over the years that followed, more loci with 
SNPs were reported at genome-wide significance (Hamshere et al., 2014).  The largest 
GWAS in schizophrenia to date, identified 108 significant genetic loci, with associations 
particularly found among genes expressed in the brain (particularly relating to abnormal 
glutamatergic synaptic and calcium channel function), providing biological plausibility for the 
findings (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014).  That 
study suggested that schizophrenia is associated with many common genetic variants each of 
small effect size.  GWAS studies have also found substantial overlap between schizophrenia, 
bipolar disorder and major depressive disorder, and a reduced, but still significant, overlap 
between schizophrenia and autistic spectrum disorder (Kavanagh et al., 2015).  The genetic 
overlap of schizophrenia with mood disorders is consistent with the clinical syndromes having 
some common symptoms, while the overlap with autism provides genetic support for 
schizophrenia being a neurodevelopmental disorder (Murray and Lewis, 1988).  It has been 
suggested that schizophrenia has a stronger neurodevelopmental component than bipolar 
disorder and lies on a gradient of decreasing neurodevelopmental impairment, between 
syndromes such as intellectual disability and autism on one hand, and bipolar disorder on the 
other (Craddock and Owen, 2010).  
 
1.5.1.3 Rare genetic variation 
Copy number variants (CNVs) are structural changes in chromosomes that result in deletions, 
duplications, inversions or translocations of large DNA segments.  Unbalanced CNVs involve 
either deletion or duplication of segments of DNA, accordingly reducing or increasing the usual 
number of copies of the segment (Kirov et al., 2015).  The earliest report of a rare genetic 
variation known to increase risk for schizophrenia, was a deletion CNV on chromosome 
22q11, which causes velo-cardio-facial syndrome, a severe genetic disorder characterised by 
a reduced IQ and a number of physical anomalies and associated with a 30% risk of 
psychosis (Murphy et al., 1999).  As new technology has permitted genome-wide CNV scans, 
so evidence has accrued for a wider role for CNVs in schizophrenia.  Eleven confirmed CNV 
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loci have now been identified as rare but important risk factors in schizophrenia (Rees et al., 
2014).  It is estimated that about 2.5% of patients with schizophrenia (and 1% of controls) 
carry a large, detectable CNV at one of these loci (Rees et al., 2014).  All CNVs for 
schizophrenia are also implicated in neurodevelopmental disorders (including autism and 
intellectual disability) and so are not specific to schizophrenia.  Penetrance (the chance that 
CNV carriers will develop the disorder) is modest for schizophrenia CNVs but much higher for 
the CNVs for neurodevelopmental disorders (Kirov et al., 2015).   
 
1.5.1.4 Summary 
Over 100 specific common risk loci (Schizophrenia Working Group of the Psychiatric 
Genomics Consortium, 2014) and at least 11 rare risk alleles (Rees et al., 2014) associated 
with schizophrenia have been identified.  Common genetic variation is thought to account for 
far more of the variance in liability to schizophrenia than rare copy number variation (Farrell et 
al., 2015).  There is evidence for shared genetic risk between schizophrenia, mood disorders 
and neurodevelopmental disorders and there is some evidence to suggest they are part of a 
spectrum (Kavanagh et al., 2015). 
 
1.5.2 Environment 
1.5.2.1 Environmental factors 
There is consistent evidence from twin and family studies for common or shared 
environmental influences on liability to schizophrenia (Lichtenstein et al., 2009, Sullivan et al., 
2003), with estimates between 4.5% and 11% respectively.  A range of prenatal infections and 
obstetric complications (in particular premature birth and low birth weight) have been identified 
as risk factors for schizophrenia (Leask, 2004) and could act to subtly deviate early brain 
development.  Childhood adversity has been shown to confer substantial risk for psychotic 
disorder (Varese et al., 2012, Morgan et al., 2014).   
 
Associations are also seen with urban life, migration and cannabis.  The association between 
urban areas and risk of schizophrenia is well established, with the incidence of schizophrenia 
increasing in a linear relationship with urbanicity as measured in terms of population size or 
density (Vassos et al., 2012).  There is also consistent and strong evidence that the incidence 
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of all psychoses is higher in many migrant and ethnic minority populations in a number of 
countries (Morgan et al., 2010) but the exact reasons for this remain unclear.  Early cannabis 
use, predating psychotic symptoms, has been shown to increase the future risk of 
schizophrenia (Arseneault et al., 2002), with meta-analyses reporting a doubling of the risk 
(Arseneault et al., 2004, Henquet et al., 2005).  Indeed cannabis use and child abuse may 
combine synergistically to increase the odds of psychotic experiences (Morgan et al., 2014).  
For these environmental factors, pooled effect sizes from meta-analyses in the range of a two- 
to four-fold increase in risk, evidence of a dose-response relationship and population 
attributable risk fractions of 20%-35% have been reported which support the validity of the 
associations but a number of methodological uncertainties remain in validating environmental 
exposures (Van Os et al., 2014).  The challenges to confirming the associations between 
environmental factors and schizophrenia include potential systematic information bias, 
confounding by genetic and other factors, and possible reverse causality.  Integrated, large-
scale longitudinal studies are required to overcome these factors and elucidate the specific 
role of environmental exposures in the aetiology of schizophrenia.  
 
1.5.2.2 Gene-environment interactions 
The gene-environment interactions (G X E) approach posits that the expression of an 
individual’s genotype depends on environmental exposure and, vice versa, the effect of 
environmental exposure on risk depends on an individual’s genotype.  As described above, 
both genetic and environmental factors have long been considered important in the aetiology 
of schizophrenia.  There is considerable variation in phenotype, as not all individuals exposed 
to environmental risk or carrying genetic risk variants develop the disorder, so G X E appears 
to be particularly relevant to schizophrenia (Van Os et al., 2014).   
 
There have been a limited number of G X E studies in schizophrenia to date, the majority of 
which examine the interaction between cannabis or stress and COMT (Modinos et al., 2013).  
Research into gene by cannabis interactions is based on the hypothesis that genetic liability to 
psychosis may be expressed as differential sensitivity to the psychotomimetic effects of 
cannabis (Kahn et al., 2011).  The first study to examine this issue (Caspi et al., 2005), utilized 
a longitudinal cohort design and found that regular use of cannabis in adolescence was 
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associated with an increased risk of developing a schizophreniform disorder in adulthood 
among carriers of the COMT Val allele.  Similarly, a further study showed that carriers of the 
COMT Val allele, but not those with the Met/Met genotype, experienced increased 
hallucinations after using cannabis (Henquet et al., 2009).  However, the findings of Caspi et 
al. (2005), were not supported by an analysis of nearly 500 cases which found no interaction 
between COMT Val158Met and cannabis use (Zammit et al., 2007).  Evidence suggests that 
people with certain genetic polymorphisms are more sensitive to stress, and stress is a trait 
which is associated with the development of psychosis; hence a small number of studies have 
explored candidate gene and stress interactions in psychosis (Modinos et al., 2013).  One 
study suggested that the COMT Val158Met polymorphism moderates affective and psychotic 
responses to stress in individuals with psychosis (Van Winkel et al., 2008).  This finding was 
later replicated, with evidence that Met/Met genotype patients showed significantly increased 
psychotic and affective reactivity to stress, compared to the Met/Val  and Val/Val genotypes 
(Collip et al., 2011).   
 
G X E is an area of development for future research in schizophrenia, with a European 
network of researchers studying gene-environment interactions involved in the development, 




Antipsychotics are the mainstay of both acute and maintenance treatment for schizophrenia.  
In first-episode schizophrenia, antipsychotics achieve symptom reduction of around 60% 
(Kahn et al., 2008).  Antipsychotic medication also significantly reduces relapse rates at one 
year, with a number needed to treat to benefit (NNT) of three (Leucht et al., 2012).  First 
generation antipsychotics (such as haloperidol) have a greater propensity to cause extra-
pyramidal side effects and tardive dyskinesia; while second-generation antipsychotics (such 
as olanzapine) have a higher propensity for metabolic side effects.  Patients and their carers 
should be involved in prescribing decisions as fully as possible.  The choice of antipsychotic 
will often be determined by the differing side effect profiles, as the magnitude of differing 
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efficacies of the various antipsychotics is small (Taylor et al., 2012).  Monitoring the 
therapeutic effect, and any side effects, of the chosen drug is crucial.   
 
If the first antipsychotic prescribed is not effective, or not tolerated, then a different 
antipsychotic should be commenced.  If poor compliance is an issue due to lack of insight, 
then a depot antipsychotic may be necessary.  If trials of two different antipsychotics have not 
been effective at controlling symptoms, then clozapine should be offered (National Institute for 
Health and Care Excellence, 2015, Taylor et al., 2012).  Clozapine is more effective than other 
antipsychotics in reducing symptoms of patients with treatment resistant schizophrenia and 
decreasing hospital admission (Wahlbeck et al., 1999, Stroup et al., 2016). 
 
1.6.2 Psychological 
A form of cognitive behavioural therapy (CBT) has been developed for psychosis and helps 
people to re-evaluate their perceptions, beliefs or reasoning relating to the target symptoms, 
with the aim of reducing distress and improving functioning.  CBT for psychosis has a small 
therapeutic effect on the symptoms of schizophrenia (Jauhar et al., 2014) and results in a 
reduction in persistent positive symptoms (Pfammatter et al., 2006).  However, CBT 
intervention had no effects on rates of remission and relapse, or number of days spent in 
hospital, and so should be reserved for those with distressing medication-unresponsive 
positive symptoms (Garety et al., 2008).  However, it has been identified as a national quality 
standard that all adults with schizophrenia are offered CBT for psychosis (National Institute for 
Health and Care Excellence, 2015), not just those with treatment-resistant positive symptoms; 
which some have argued is contrary to the evidence base (Perera and Taylor, 2014). 
 
Family therapy includes psychoeducation for the patient and family members.  
Psychoeducation has been shown to improve compliance and reduce relapses in patients with 
schizophrenia (Morin and Franck, 2017).  The specific aims of family therapy include: 
identifying precipitating stresses and likely future stresses inside and outside the family, 
planning strategies for managing these stresses, and accepting the reality of the illness and 
the need for treatment.  Family intervention can improve coping skills and relapse rates of 
adults with schizophrenia and should be offered to all families (National Institute for Health and 
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Care Excellence, 2015).  However, evidence suggests that people with schizophrenia have 
poor access to the recommended psychological interventions (Berry and Haddock, 2008). 
 
1.7 Summary 
Schizophrenia is a severe and enduring mental illness which has a significant impact on the 
wellbeing of patients and their families.  It is characterized by delusions, hallucinations and 
thought disorder, and cognitive deficits are common.  Its aetiology is complex and 
multifactorial, with evidence of both genetic and environmental influences.  Antipsychotics are 
the mainstay of treatment and CBT for psychosis may be a beneficial adjunct for those with 





Chapter 2 Selective Review of the Literature Relating to 
Schizophrenia and Violence 
 
2.1 Abstract 
This chapter describes the current literature relating to the link between schizophrenia and 
violence.  It focuses on the clinical and biological factors which have been proposed to explain 
this association, including psychotic symptoms and co-morbid substance misuse and 
preliminary evidence of biological mechanisms from genetics and imaging studies.  The 
emerging importance of premorbid conduct disorder in a potential pathway to violence in 
schizophrenia is discussed.  It is concluded that supporting evidence is mixed and specific 
drivers for the association between schizophrenia and violence remain unclear.    
 
2.2 Background 
Understanding the pathways to violence in people with schizophrenia is crucial for risk 
management and effective treatment, however these pathways remain unclear.  This is a vital 
issue, as almost 20% of patients with schizophrenia in the community will behave violently in a 
six month period (Swanson et al., 2006).  This violent behaviour has far reaching ramifications 
for the patient, their families and society.  The emotional cost of violent behaviour is extremely 
high for both patients and relatives.  This is often compounded by close family members being 
the victims of the violent incident, with family members being the victim in half of homicides 
committed by patients with schizophrenia compared to around a third in homicides committed 
by the general population (Meehan et al., 2006).  A criminal justice pathway to psychiatric care 
is more common in first episode of psychosis if there has been violent behaviour and is 
associated with a longer duration of untreated psychosis (Bhui et al., 2015).  These patients 
often need several years’ of treatment in a secure hospital and intensive, long-term follow-up 
in the community, necessitating considerable financial resources.  Whilst understanding the 
causes of violence in schizophrenia is crucial, it is also important to remember that people with 
severe mental illnesses are much more likely to be the victims of violent crime than the 




There are many definitions of violence, one that is used commonly in clinical practice is: 
‘actual, attempted, or threatened harm to a person or persons’ (Webster et al., 1997).  The 
term aggression is often used interchangeably with violence in the literature, despite different 
operational definitions (Serper, 2011).  Aggression can be defined as any behaviour directed 
toward another individual that is carried out with the intent to cause harm (Anderson and 
Bushman, 2002).  In contrast to violence, however, an act can be termed as aggressive even 
if it is not behaviourally expressed or no physical harm is sustained (Serper, 2011).  Violence 
is generally, therefore, regarded as a more extreme form of aggression.  The definition of 
violence and its measurement is discussed further in chapter 3. 
 
At the commencement of this research study, there were two recent systematic reviews and 
meta-analyses (Douglas et al., 2009, Large and Nielssen, 2011) which examined the 
association between schizophrenia and violence.  These papers formed the starting point of 
this selective review of the literature and allowed identification of the broad areas of interest of 
psychotic symptoms, antisocial personality disorder, substance misuse and childhood 
adversity.  These topic areas were explored in more detail by examination of the original 
papers included in the meta-analyses, database searches and cross-referencing with other 
papers.   In addition, genetics and imaging were emerging areas of research into 
schizophrenia and violence, although the number of studies is quite limited; these literature 
searches are described in 2.7.1 and 2.8.1. 
 
2.3 Psychotic symptoms 
Epidemiological studies have provided good evidence of a modest but clinically and 
statistically significant association between schizophrenia and the risk of violence (Douglas et 
al., 2009, Walsh et al., 2002, Arseneault et al., 2000, Large and Nielssen, 2011, Fazel et al., 
2014).  These studies have identified between a four- to six-fold increased risk of violent 
behaviour in schizophrenia (Fazel et al., 2009).  Psychotic symptoms were an initial focus of 




2.3.1 Positive psychotic symptoms 
Several studies have concluded that the presence of positive psychotic symptoms 
(hallucinations and delusions) are associated with an increased risk of violence (Hodgins et 
al., 2003, Krakowski et al., 1999, Swanson et al., 2006, Daffern et al., 2005, Keers et al., 
2014).  However, other studies did not find evidence to support this association (Dean et al., 
2007, Harris et al., 2010).   
 
The MacArthur study was a highly influential prospective investigation that followed more than 
1100 patients discharged from hospital to the community for one year, assessing them every 
10 weeks, and compared them with people living in the neighbourhoods they were discharged 
to (Steadman et al., 1998).  The study found that, in the absence of symptoms of substance 
abuse, there was no significant difference between the prevalence of violence by patients and 
by the general population (Steadman et al., 1998).  The investigators also specifically found no 
association between any type of delusions and violence (Appelbaum et al., 2000).  However, a 
reanalysis of data from the MacArthur study, carefully considering temporal proximity, 
indicated a relationship between several delusions and violence (Ullrich et al., 2014) (see 
section 2.3.2 below). 
 
Threat/control-override symptoms, principally delusions of persecution (threat) and passivity 
(control-override), were advanced as a cognitive model for violence in psychosis (Link and 
Stueve, 1994).  Initially this theory was corroborated by other studies (Link et al., 1998, 
Swanson et al., 1996, Swanson et al., 1997), however evidence from later studies did not 
support this (Appelbaum et al., 2000, Haddock et al., 2013).  However, threat, but not control-
override symptoms, have emerged as being a significant factor in aggressive behaviour in 
patients with psychosis (Nederlof et al., 2011, Stompe et al., 2004).  Control-override 
symptoms (passivity) can be seen as more or less typical of schizophrenia.  However, it has 
been noted that the threat symptoms encompass paranoia more generally, hence are 
comparatively unspecific and may occur widely outside of a schizophrenic illness (Stompe et 




When considering paranoia more widely, rather than persecutory delusions, one study found 
that an association between aggression and psychosis proneness (sub-clinical psychotic 
symptoms) in the general population was mediated by threat (Fanning et al., 2011).  A 
systematic review of paranoia and aggression in psychosis identified fifteen studies, primarily 
cross-sectional in design, which showed mixed support for an association between paranoia 
and aggression in both inpatients and community settings (Darrell-Berry et al., 2016).  
However, the authors noted that more methodologically rigorous studies tended to show a 
positive association between the factors.  These findings are not isolated to patients and are 
also reflected in the general population.  Data have demonstrated that paranoid ideation on a 
psychosis-continuum in the general population (without a psychotic disorder) was associated 
with violence severity and frequency (Coid et al., 2016), illustrating that paranoia is not just 




There is an emerging literature exploring emotional reactions to psychotic symptoms, 
particularly anger, as possible correlates of aggressive behaviour in schizophrenia.  Command 
hallucinations to harm others are associated with violence (McNiel et al., 2000), although not 
all studies have supported this finding (Haddock et al., 2013), and it has been demonstrated 
that anger and impulsivity are important in predicting compliance with command hallucinations 
to do harm (Bucci et al., 2013).  Distress caused by the delusion partly explains the 
relationship between persecutory delusions and aggression (van Dongen et al., 2012).  
However, another study did not find a link between distress caused by a delusion and harming 
others (Haddock et al., 2013).  An early study suggested that violent patients, rather than a 
non-violent group, were more likely to report that their delusion made them angry (Cheung et 
al., 1997b).  Delusional beliefs implying threat were associated with serious violence but were 
mediated by anger due to the delusion (Coid et al., 2013).  A reanalysis of data from the 
MacArthur study, considering temporal proximity, indicated a relationship between several 
delusions and violence, and that angry affect due to the delusions was the key factor in this 
pathway (Ullrich et al., 2014).  A systematic review of angry affect and violence in the context 
of a psychotic illness, found that all studies reported higher anger scores for individuals with 
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schizophrenia who acted violently compared with the non-violent group (Reagu et al., 2013).  
Although the anger reported in these studies was noted to be related to active symptoms of 
schizophrenia, other factors that may provoke anger and could be present in individuals 
without psychosis may have played a role.  Therefore, there are indicators that anger in 
response to delusions may be important in whether these beliefs are associated with violent 
behaviour.   
 
2.3.3 Treatment 
If psychotic symptoms are associated with violence then a logical hypothesis is that treating 
these symptoms with antipsychotics will reduce the risk of violence.  The important moderating 
effect of treatment was highlighted by a meta-analysis of violence in first episode psychosis, 
which demonstrated that homicides were perpetrated by 1 in 630 new first episode patients 
and were associated with a longer duration of untreated psychosis (Large and Nielssen, 
2011).  Furthermore, non-adherence with medication is associated with violence in psychosis 
(Witt et al., 2013).  More specifically the absence of treatment in schizophrenia is associated 
with violence, mediated by the emergence of persecutory delusions (Keers et al., 2014).  
Interestingly, clozapine is an antipsychotic that is considered to have specific anti-aggression 
action in schizophrenia (Frogley et al., 2012). 
 
2.4 Conduct disorder, antisocial personality disorder and 
psychopathy 
2.4.1 Conduct disorder 
Conduct disorder (CD) reflects a pattern of persistent antisocial behaviour prior to the age of 
15, symptoms described in DSM-IV include: initiating physical fights; forcing someone into 
sexual activity; being physically cruel to animals; deliberately destroying others’ property; fire-
setting with the intention of causing serious damage (First et al., 1997).  CD is over-
represented in patients with schizophrenia (Hodgins et al., 2008, Kim-Cohen et al., 2003) and 
is associated with an increased risk of violent behaviour in schizophrenia (Arseneault et al., 
2000, Hodgins et al., 2008, Swanson et al., 2008).  Indeed each CD symptom present before 
the age of 15 is associated with an increased risk of violent behaviour in adulthood in those 
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with severe mental illness (Hodgins et al., 2008, Hodgins et al., 2005).  It may be that the 
clinical and non-clinical variables associated with violence differ in patients with schizophrenia 
with and without CD (Hodgins, 2008, Swanson et al., 2008, Heads et al., 1997).  Therefore the 
factors that increase the risk of violence in schizophrenia may differ between those with and 
without prior CD.  This makes it particularly important to consider the presence or absence of 
CD in violent patients with schizophrenia in future research that seeks to understand the 
nature of the association between schizophrenia and violence.     
 
2.4.2 Antisocial personality disorder 
Fewer than half of those with CD prior to the age of 15 will go on to develop adult antisocial 
personality disorder (Blair et al., 2014).  In DSM-IV, a diagnosis of antisocial personality 
disorder (ASPD) requires evidence of CD prior to the age of 15 (First et al., 1997).  ASPD is 
characterized by features such as a reckless disregard for the safety of self and others, 
deceitfulness, irritability and aggressiveness and consistent irresponsibility.  People with 
ASPD have an increased risk of violence (Yu et al., 2012), including among those who also 
have schizophrenia (Volavka, 2014, Bo et al., 2013).  
 
2.4.3 Psychopathy 
A minority of those with ASPD are characterized by deficient affective experience, typified by a 
lack of empathy and remorse, as well as persistent reactive and instrumental aggression, and 
meet diagnostic criteria for psychopathy (Gregory et al., 2012) as defined by the Psychopathy 
Checklist-Revised (Hare et al., 1990).  Psychopathy is significantly associated with violence 
and makes a substantial impact on violence among the general population despite its low 
prevalence (Coid and Yang, 2011).  So although it is an uncommon condition, individuals with 
psychopathy are responsible for a considerable proportion of violence in the population.  It is 
recognized that in forensic psychiatric settings, between 20% and 30% of patients with 
schizophrenia have high psychopathy scores (Dolan and Fullam, 2009).  A range of studies 
conclude that psychopathy is an important predictor of future violence in schizophrenia 
(McGregor et al., 2012, Tengström et al., 2004, Tengström et al., 2000, Abushua'leh and Abu-
Akel, 2006).  There is some evidence that patients with schizophrenia and high psychopathy 
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scores may have more clinical characteristics in common with other offenders with 
psychopathy rather than other offenders with schizophrenia (Laajasalo et al., 2011, Bo et al., 
2011). 
 
2.5 Substance misuse 
Substance misuse is associated with violence both in the general population (Coid et al., 
2006, Fazel et al., 2009) and in people with schizophrenia (Swanson et al., 2006, Fazel et al., 
2009), though controversy remains about the extent of its role in mediating the risk of violence 
in schizophrenia.  Some evidence shows that substance misuse is one of multiple factors that 
increase the risk of violent behaviour in patients with psychotic illnesses (Daffern et al., 2005, 
Harris et al., 2010, Stompe et al., 2004); while other data suggests that the increased risk of 
violence is primarily mediated by co-occurring substance misuse, with a much lesser role for 
other factors (Elbogen and Johnson, 2009, Fazel et al., 2009).  Adding complexity to this 
debate, a reanalysis of data from one of these studies (Elbogen and Johnson, 2009) found 
that those with severe mental illness, irrespective of the presence of substance abuse, were 
significantly more likely to be violent than those with no mental illness (Van Dorn et al., 2012), 
a finding later confirmed specifically for schizophrenia (Short et al., 2013).  In short, it is now 
generally accepted that there is an increased risk of violence in schizophrenia, independent of 
co-morbid substance misuse, though substance misuse further increases that risk.     
 
2.5.1 Substance misuse and conduct disorder 
However the link between substance misuse and violence in schizophrenia may involve a 
more complex interaction with CD.  Substance misuse is itself not a diagnostic criterion for CD, 
though CD is associated with an increased risk of substance abuse (Blair et al., 2014) and an 
increased risk of starting to use all classes of substances before the age of 18 (Hopfer et al., 
2013).  It may be that substance misuse occurs more commonly in patients with schizophrenia 
who had pre-morbid CD (Hodgins et al., 2005).  However, lower levels of substance use may 
be associated with violence in those with CD compared to those without CD (Swanson et al., 
2008).  Therefore there appear to be interactions between pre-morbid conduct disorder, 
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substance misuse, and risk of violence in schizophrenia that may represent a trajectory from 
early CD to violence in adulthood.   
 
2.6 Childhood adversity 
Childhood physical abuse has been shown to be associated with later violent behaviour in 
general population (Elbogen and Johnson, 2009), patient (Hoptman et al., 1999, Witt et al., 
2013) and prisoner (Sarchiapone et al., 2009) samples.  However, less is known about the 
influence of other forms of childhood trauma on the risk of violence in people with 
schizophrenia.   
 
Childhood adversity, that can occur in a variety of forms, is strongly associated with an 
increased risk for psychosis and could have a significant aetiological role (Varese et al., 2012).  
For example, a prospective study in adolescents showed that childhood trauma was strongly 
predictive of new adolescent psychotic experiences and that stopping the trauma ceased the 
psychotic experiences (Kelleher et al., 2013).  There is also evidence that childhood abuse 
and the number of later life events combine synergistically to increase the odds of psychotic 
experiences beyond the effects of each risk factor alone (Morgan et al., 2014).  However, 
other forms of childhood adversity, such as parental loss or separation also contribute to later 
psychopathology (Morgan et al., 2007).  Hence there is a wider focus on the effects of 
childhood adversities in psychosis, rather than exclusively childhood trauma (Varese et al., 
2012).   
 
2.6.1 Childhood adversity and conduct disorder 
Childhood adversity, including neglect and physical and sexual abuse, increases the risk of 
CD (Afifi et al., 2011, Foley et al., 2004, Maniglio, 2015, Villodas et al., 2014); while as already 
seen, CD is over-represented in patients who later develop schizophrenia (Hodgins et al., 
2008).  Patients with schizophrenia are more likely to have been exposed to a variety of 
adverse childhood events including physical and sexual abuse; parental divorce, parental 
death; domestic violence; and foster care (Gibbon et al., 2009, Rosenberg et al., 2007, 
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Bennouna-Greene et al., 2011).  In summary, there is emerging evidence that childhood 
adversity, perhaps acting at critical periods of childhood development, is associated with CD, 
psychosis, and the risk of violence.   
 
2.7 Genetics 
2.7.1 Search strategy 
A database literature search and manual cross referencing was conducted or English 
language studies relating to genetic studies in violent patients with schizophrenia.  The 
following databases were searched: Scopus, EMBASE (1980-present), OVID Medline (1948-
present), PsychINFO (2002-present); using combinations of the following search terms: 
schizophrenia, psychosis, gene*, COMT, MAO-A, antisocial, aggressi*, violen*.  
 
2.7.2 Monoamine oxidase 
Monoamine oxidase (MAO-A) is a critical regulator of monoaminergic neurotransmitter 
signalling, including at dopaminergic synapses throughout the brain.  Its role in aggression has 
been implicated in animal and human models (Cases et al, 1995; Brunner & Nelen,1993; 
Buckholtz & Meyer-Lindenberg, 2009).  However the studies in schizophrenia and violence 
have had largely negative results (see table 2-1). Four studies, including a total of 901 
subjects, found no association between violence (Nolan et al., 2000, Koen et al., 2004) or 
aggression (Strous et al., 2003, Zammit et al., 2004) and MAO-A.  One study considered 
agitation in patients with schizophrenia (Nikolac Perkovic et al., 2016), and also found no link 
to MAO-A.  There was only one study that found a positive association between aggression 
and MAO-A (Fresan et al., 2007).  
 
2.7.3 Catechol-O-methyltransferase 
Perhaps more promising is the link between the catechol-O-methyltransferase (COMT) gene, 
schizophrenia and violence.   COMT is one of the enzymes responsible for the catabolism of 
dopamine and noradrenaline in the brain.  The Val allele of the COMT gene is associated with 
high enzymatic activity, whereas the Met allele is associated with low enzymatic activity.  
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Therefore the Met allele is associated with increased levels of catecholamines in the prefrontal 
cortex, which are associated with aggression in schizophrenia (Nolan et al., 2004, Soyka, 
2011).  Ten of thirteen studies of the COMT gene and violence in schizophrenia have 
suggested a significant association (see Table 2-1).  Indeed two meta-analyses concluded that 
the Met allele of the COMT gene confers a significantly increased risk for violent behaviour in 
men with schizophrenia (Bhakta et al., 2012, Singh et al., 2012).   
 
Table 2-1 Genetic studies of association between schizophrenia and violence 
Author Measure Instrument Genes n (total) Results 
Strous 
(1997) 
aggression records, history COMT 37 positive 
Lachman 
(1998) 
violence records, history COMT 55 positive 
Kotler 
(1999) 
homicide records, history COMT 92 positive 
Nolan 
(2000) 






aggression OAS COMT 180 positive 
Strous 
(2003) 



























OAS COMT 132 positive 
Fresan 
(2007) 













OAS COMT 165 positive 
Tosato 
(2011) 
aggression OAS COMT 80 positive 
Koh  
(2012) 






aggression OAS BDNF 579 negative 
Perkovic 
(2016) 
agitation OAS, PANSS, PCL MAO-A 363 negative 
COMT = catechol-O-methyltransferase; MAO-A = monoamine oxidase A variant; TPH = tryptophan 
hydroxylase 1; BDNF = brain-derived neurotrophic factor; DRD4 = dopamine receptor D4; OAS = Overt 
Aggression Scale; PANSS = Positive And Negative Syndrome Scale; PCL = Psychopathy Checklist; 




2.8.1 Search strategy 
A database literature search and manual cross referencing was conducted or English 
language studies relating to imaging studies in violent patients with schizophrenia.  The 
following databases were searched: Scopus, EMBASE (1980-present), OVID Medline (1948-
present), PsychINFO (2002-present); using combinations of the following search terms: 
schizophrenia, psychosis, imaging, MRI, antisocial, aggressi*, violen*.  
 
2.8.2 Structural imaging 
The results of the structural magnetic resonance imaging studies of violence in schizophrenia 
are summarized in Table 2-2.  Region of interest (ROI) studies examine only certain brain 
regions hypothesized to be associated with the dependent variable, whereas whole brain 
studies investigate volume differences across the entire brain.   Five of the structural imaging 
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papers were ROI studies and the remainder adopted a whole brain approach.  The majority of 
papers identified presented results from two cohorts of patients.  There are also considerable 
methodological inconsistencies across the imaging studies of schizophrenia and violence, 
including the definitions of violence employed and the inclusion of patients with co-morbid 
ASPD and substance misuse.   
 
Table 2-2 Structural magnetic resonance imaging studies of schizophrenia and violence 



























13 SCZ + V 
15 SCZ - V 
13 ASPD + V 
15 C – V 

















12 SCZ + V 
15 SCZ - V 
14 ASPD + V 
15 C - V 
GRVS Medial inferior frontal 








13 SCZ + V 












10 SCZ + V 
14 SCZ - V 
14 C - V 
GRVS Hippocampus 
Orbitofrontal 
Reduced grey matter 
volume 
Lui    
(2009) 
68 SCZ (first 
episode) 
68 C 
PANSS Right anterior 
cingulate and middle 
temporal gyri 





32 SCZ + V 
33 SCZ - V 
31 C + V 
14 other illness 
+ V 
47 C - V 
Homicide Right middle frontal 
and left inferior 
frontal gyri 
Later birth order 
associated with 




22 SCZ + V 
19 SCZ - V 
18 C + V 










13 SCZ + V 
15 SCZ - V 
13 ASPD + V 







27 SCZ + CD 
23 SCZ – CD 
27 CD 
25 C 




33 SCZ or 
SCZA 
31 C 
LHA & BPAQ  Right frontal pole 
Medial and lateral 
orbitofrontal gyri and 
inferior frontal gyri 
Anterior cingulate  
Reduced cortical 
thickness 
ROI = region of interest study; SCZ = schizophrenia; SCZA = schizoaffective disorder; ASPD = antisocial personality 
disorder; CD = conduct disorder; V = violent; C = control; OAS = Overt Aggression Scale; BDHI = Buss Durkee 
Hostility Inventory; PANSS = Positive And Negative Syndrome Scale; GRVS = Gunn Robertson Violence Scale; LHA 




These results provide consistent evidence, from both ROI and whole brain studies, of reduced 
grey matter volume in the hippocampus in patients with schizophrenia who are violent 
compared to those who are not (Barkataki et al., 2006, Yang et al., 2010, Kumari et al., 2009a, 
Kumari et al., 2013).  There is also evidence of grey matter abnormalities in the inferior frontal 
region (Hoptman and Antonius, 2011, Narayan et al., 2007, Schug et al., 2010, Hoptman et 
al., 2014).  Some results are conflicting, for example one study found that increased grey 
matter in the orbitofrontal region was associated with aggression (Hoptman et al., 2005) but 
another found decreased grey matter in the same region was associated with violence 
(Kumari et al., 2009a).  One region of interest study found an association between increased 
volume of the caudate and aggression (Hoptman et al., 2006) but this region has not been 
identified in whole brain studies.  One of the most relevant confounding factors that may 
explain some of the variance in these studies is the effect of antipsychotic medication on brain 
volumes (Soyka, 2011).  It is recognised that the neuroimaging literature in schizophrenia and 
violence is in a period of development, in part attributable to the heterogeneous nature of 
violence and its measurement (Hoptman and Antonius, 2011).   
 
2.8.3 Functional imaging 
The results of the functional magnetic resonance imaging studies are summarized in Table 
2-3.  In brief, they show reduced frontal lobe activity in response to a working memory task 
and reduced activity in the prefrontal cortex, thalamus and caudate during the condition 
requiring inhibition a response inhibition task.  There is some evidence of differing findings in 
patients with co-morbidities such as ASPD and psychopathy.  There is early but consistent 
evidence of reduced resting state functional connectivity between frontal and medial temporal 









Table 2-3 Functional magnetic resonance imaging studies of schizophrenia and violence 
Author Sample Measure of 
violence 






13 SCZ + V 
12 SCZ - V 
10 ASPD + V 

















12 SCZ + 
ASPD + SUD 
12 C - V 
Homicide Go/no-go Prefrontal 
cortex 
Reduced activity 
in go/no-go task 





12 SCZ + V 
12 SCZ - V 
14 ASPD + V 
14 C - V 
GRVS Go/no-go Thalamus 
Caudate 
Reduced activity 
in go/no-go task 
Kumari 
(2009b) 
13 SCZ + V 
13 SCZ - V 
13 ASPD + V 
14 C - V 












response to threat 
Dolan 
(2009) 
12 SCZ + V + 








to fearful faces in 
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12 SCZ + V + 






25 SCZ or 
SCZA 








































SCZ = schizophrenia; SCZA = schizoaffective disorder; ASPD = antisocial personality disorder; V = violent; C = 
control; OAS = Overt Aggression Scale; PANSS = Positive And Negative Syndrome Scale; GRVS = Gunn Robertson 
Violence Scale; LHA = Life History of Aggression scale; PCL-SV = Psychopathy Checklist Screening Version; BPAQ 
= Buss Perry Aggression Questionnaire 
 
2.8.4 Implications 
The studies summarized above represent the totality of the neuroimaging evidence relating to 
schizophrenia and violence.  Six of the papers identified presented results from the same 
cohort of patients.  There are a very small number of studies, with modest sample sizes, and 
so the current evidence in this area is limited.  There are also considerable methodological 
inconsistencies across these imaging studies in the definitions of violence employed (e.g. 
convictions, self-report, type and severity of violence) and in the inclusion of patients with co-
morbid antisocial personality disorder (ASPD) and substance misuse.   
 
Despite the methodological challenges, there is emerging evidence that patients with 
schizophrenia who are violent are characterized by a number of biological markers, principally 
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centred on medial temporal and frontal lobe volume deficits.  There is evidence of generally 
impaired neural activity with some very early evidence of disordered structural and functional 
connectivity.  More detailed investigation of violence in patients with schizophrenia, with 
appropriate consideration of the relevant co-morbidities, including antisocial personality 
disorder and substance misuse is required to elucidate which deficits, if any, are specific to 
violence in schizophrenia. 
 
2.9 Challenges of research into violence and schizophrenia 
2.9.1 Violence definition 
Many previous studies have considered violent offending in schizophrenia as a homogenous 
entity.  The studies reviewed varied considerably in terms of the definition of violence 
employed.  Most studies used either a dichotomous measure of the presence or absence of 
violence, or of severe and less severe violence (the threshold often being assault causing 
injury or similar).  The methods of obtaining information included self-report, criminal records, 
medical records and informants, either alone or in combination.  Means of assessment 
included PANSS, OAS and criminal convictions.  The variations cause challenges in 
comparing the results of studies.  There would be benefits of utilizing a scale measure of 
violence to produce richer data (see chapter 3 for a wider discussion). 
 
2.9.2 Co-morbidities 
Study samples have usually included patients with a range of other co-morbidities, that 
themselves are independently associated with violence risk within the same experimental 
groups, for example antisocial personality disorder and substance misuse.  This 
methodological limitation makes it then difficult to distinguish factors relating to violence 
associated with these co-morbidities from those specific to schizophrenia.  The picture is 
further complicated by the use in previous studies of the broad term of psychosis rather than 
schizophrenia.   It has been suggested that one way of differentiating sub-groups of patients 
with schizophrenia with differing propensities to violence is the presence of co-morbid CD.  




2.10 Typologies of violence in schizophrenia 
The findings reviewed in this chapter, have led to the suggestion that violence among patients 
with schizophrenia may follow at least two distinct pathways, one associated with premorbid 
conditions, including CD, and another linked with the acute psychotic symptoms of 
schizophrenia (Volavka, 2014, Bo et al., 2011, Volavka and Citrome, 2011, Hodgins et al., 
2014).  One way of conceptualizing these two pathways, has been the early-start offender and 
the late-start offender, which is a typology that has previously been applied to all criminal 
offenders and more recently to those with schizophrenia.  Early-start offenders have higher 
rates of substance use disorders and higher psychopathy scores in adulthood than late-start 
offenders (Tengstrom et al., 2001, Van Dongen et al., 2014).  It is suggested that late-start 
offending is primarily driven by positive psychotic symptoms rather than antisocial traits (Van 
Dongen et al., 2015).  
 
Therefore, in an attempt to differentiate between patterns of violent behavior in schizophrenia, 
it has been proposed that future studies should distinguish between patients with 
schizophrenia with and without prior conduct disorder (Hodgins, 2008, Tengstrom et al., 2001).  
Hypothetically, these groups may differ both in key neurodevelopmental and more proximal 
risk factors, such as psychotic symptoms and drug misuse, which act to influence the risk of 




There is a modest but statistically significant association between schizophrenia and violence.  
However, this link has massive clinical, societal and personal implications and contributes to 
increased stigma around mental illness.  The specific drivers and their relative contributions to 
this association remain unclear.  CD is over-represented in patients with schizophrenia and is 
associated with an increased risk of adult violent behaviour.  Those with CD are more likely to 
experience childhood abuse and substance misuse, both of which are also associated with an 
increased risk of violence.  Therefore, the relationships in early life between CD, childhood 
adversity and substance misuse may be of particular importance in understanding the 
pathway to violence in people with schizophrenia.  Once the psychotic symptoms of the illness 
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are manifest, the evidence is mixed regarding whether hallucinations and delusions are linked 
to violence.   However, there is emerging evidence that angry affect in response to delusions 
may mediate the association between delusions relating to threat and violent behaviour.   
 
The genetic and neuroimaging literature on violence in schizophrenia is in a period of 
development.  However, there is evidence that the Met allele of the COMT gene confers a 
significantly increased risk for violent behaviour in men with schizophrenia.  In relation to 
imaging, there is almost entirely consistent evidence of reduced grey matter volume in the 
hippocampus in patients with schizophrenia who are violent.    There is further evidence of 
probable grey matter volume loss and early evidence of impaired structural and functional 









Harris, S.T.*, Oakley, C.*, Picchioni, M. 2013. Quantifying violence in mental health research. 
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3.1 Introduction to published paper 
This paper describes a systematic review to identify and evaluate tools to assess violent 
behaviour.  It was conducted as a means of identifying the best method of measuring and 
quantifying violence to utilise in this research study.  As described in 2.9.1, many previous 
studies have considered violent offending in schizophrenia as a homogenous entity.  It was 
considered important for this study, not to use a dichotomous presence or absence of violence 
to categorise participants, but to use a measure which allowed a richer data set relating to a 
range of violent behaviour.  Therefore, the following paper aimed to assist in determining the 
























3.2 Validity and reliability of tools 
The measures of inter-rater reliability and concurrent validity of the tools described in the 
published paper above are summarised in table 3-1 below. 
 
Table 3-1 Reliability and validity of violence measurement tools 




Gunn Robertson Scale  
(Gunn and Robertson, 1976) 
 
0.92 Value not reported 
Modified Overt Aggression 
Scale (Kay et al., 1988)  
 
Between 0.85 and 0.94 Value not reported 
Violence Scale (Morrison, 
1993)  
 
0.69 Value not reported 
Lifetime History of 
Aggression (Coccaro et al., 
1997) 
0.95 0.45  
MacArthur Community 
Violence Instrument 
(Steadman et al., 1998) 
Value not reported Value not reported 
Liverpool Violence 
Assessment (Nathan et al., 
2003) 
0.96 0.41 
Quantification of Violence 
Scale (Tyrer et al., 2007) 
 
0.69 0.67 
Actual and Attempted Assault 
Scale (Bowers et al., 2007) 
 
0.7 0.7 
Crime and Violence Scale 
(Conrad et al., 2010)   
 





As a result of this systematic review, we concluded that the Gunn Robertson Violence Scale 
(Gunn and Robertson, 1976), was the most appropriate tool to utilise in this study.  This 
decision was based on its excellent inter-rater reliability, that it assessed information from both 
self-report and official records, and that it was a five-point scale which allows for assessment 
of a range of severities of violent behaviour.   
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Chapter 4 Methodology 
 
4.1 Abstract 
This chapter describes the general methodology for the study, including recruitment of 
participants, clinical assessments undertaken and statistical analyses. 
  
4.2 Aims 
This study aimed to identify and define the clinical correlates underlying violent behaviour in 
schizophrenia.  It specifically sought to examine the putative role of childhood adversities, 
conduct disorder and co-morbid substance misuse.  On the basis of the existing literature, in 
order to define more precisely the factors that predispose to violence in men with 
schizophrenia, recruited patients were assessed for symptoms of prior conduct disorder in 
addition to their history of violence.  The study aimed to recruit patients from a wide range of 
mental health settings, including outpatients and inpatients in both secure and non-secure 
units. 
 
While the link between schizophrenia and violence is clear (see chapter 2); at present we 
understand very little about which patients with schizophrenia will behave violently and under 
what circumstances, so prediction and prevention is challenging, but a vital public health and 
human rights issue.  Therefore, the longer term objective is that the results of this study will 
inform future developments in the assessment of the risk of violence in schizophrenia and 
improve the treatment of these patients to reduce the risk of violence.   
 
4.3 Ethical approval 
The Birmingham East, North and Solihull NHS Research Ethics Committee approved the 
study in December 2010.  Three substantial amendments were later approved in July and 
October 2011 and February 2012.  Minor amendments were also approved in February 2011 
and March 2014. NHS Research & Development approval was obtained for each recruiting 
NHS trust: 
 Birmingham and Solihull Mental Health NHS Foundation Trust (August 2011) 
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 Northamptonshire Healthcare NHS Foundation Trust (December 2011) 
 Oxford Health NHS Foundation Trust (May 2012) 
 Leicestershire Partnership NHS Trust (September 2012) 
Local Research & Development approval was obtained for one non-NHS site (St Andrew’s 
Healthcare – Northampton, Birmingham and Essex sites).   
 
4.4 Power calculation 
I conducted a power calculation under the supervision of the Biostatistics Department at the 
Institute of Psychiatry, Psychology and Neuroscience using G*Power 3 (Faul et al., 2007).  A 
power calculation provides an estimate of an adequate sample size to detect the effects 
hypothesised in the study.  Similar studies with the same dependent variable were identified 
but none had utilised the five-point scale of the Gunn Robertson Violence Scale.  Therefore, it 
was necessary to consider studies using the presence or absence of violence instead in order 
to undertake the power calculation.  A study with the required clinically significant effect sizes 
and reported standard deviations was identified following advice from the Biostatistics 
Department; the calculation used primary outcome data from Arango et al. (1999) for 
prediction of violence in patients with schizophrenia with positive psychotic symptoms.  
Analysis of Variance at the 0.05 significance level would have 80% power to detect a 
significant difference in Positive and Negative Syndrome Scale (Kay et al., 1987) positive 
psychotic symptoms scores between patients with schizophrenia with and without a history of 
violence (difference in means 5.5 and parsimoniously assuming a common standard deviation 




4.5.1 Inclusion criteria 
Inclusion criteria for all participants were: 
 male 
 between 18 and 65 years 




Additionally for patients, they had: 
 a primary diagnosis of schizophrenia 
 capacity to consent to participate  
 
4.5.2 Exclusion criteria 
Participants were excluded if they had a: 
 history of epilepsy  
 history of significant head injury (loss of consciousness for more than 3 minutes or 
requiring hospitalisation)  
 learning/intellectual disability or dementia  
 history of neurological disorder  
 current active substance abuse/dependence  
 history of mania or hypomania 
 
4.5.3  Recruitment 
Patients with schizophrenia were recruited from four large NHS Mental Health Trusts: 
Birmingham and Solihull Mental Health NHS Foundation Trust, Northamptonshire Healthcare 
NHS Foundation Trust, Oxford Health NHS Foundation Trust and Leicestershire Partnership 
NHS Trust. Each Trust provides general adult and forensic psychiatric services to working age 
adults in their respective catchment areas.  Each Trust was considered to offer representative 
sampling of male patients with schizophrenia, as they offered secondary and tertiary mental 
healthcare services for patients with schizophrenia in their respective catchment areas.  
Recruitment included one independent organization that cared for NHS patients, St Andrew’s 
Healthcare with hospitals in Essex, Northampton and Birmingham.  Potential candidates were 
identified by their Responsible Clinicians and once they agreed were referred to the study. 
 
Healthy control participants were recruited from the local area by newspaper advertisements 
and posters and flyers in local shops and businesses.  This aimed to recruit a representative 





4.6 Clinical assessments 
4.6.1 Schizophrenia 
4.6.1.1 Diagnosis 
The Structured Clinical Interview for DSM-IV Axis I disorders (SCID-I) (First et al., 2002) was 
used to diagnose schizophrenia and any mood disorders.  This consisted of a structured 
clinical interview and review of the patients’ medical records. 
 
4.6.1.2 Symptoms 
As part of the SCID-I assessment the lifetime presence of a range of psychotic symptoms was 
elicited.  This was augmented by specific questions to identify any threat/control-override 
symptoms (Stompe et al., 2004).  Threat symptoms are clear, unequivocal persecutory 
delusions that impose a feeling of imminent danger on the patient.  Control-override symptoms 
are passivity phenomena comprising external interference.  Psychotic symptoms at the time of 
the assessment were evaluated using the Positive and Negative Syndrome Scale (PANSS) 
(Kay et al., 1987).  This widely used scale comprises 7 items relating to positive symptoms of 
psychosis (e.g. delusions), 7 items relating to negative symptoms (e.g. emotional withdrawal) 
and 16 items relating to general psychopathology (e.g. anxiety). All 30 items are rated on a 7 
point scale from absent to extreme.  Scores range from 7 to 49 for the positive and negative 
scales and 16 to 112 for the general psychopathology scale. 
 
Patients’ insight into their mental illness was assessed using the self-report Insight Scale 
(Birchwood et al., 1994).  The scale considers three factors (awareness of illness, need for 
treatment and attribution of symptoms) by way of eight questions.  The maximum score is 12, 
with 0 indicating no insight and 9 or above considered to represent good insight. 
 
4.6.1.3 Current functioning 
The Global Assessment of Functioning scale (GAF) from the SCID-I (First et al., 2002) was 
used to obtain a measure of the participant’s overall social, occupational and psychological 
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functioning at the time of the assessment.  It is an ordinal scale from 1-100 on a hypothetical 
continuum of mental illness-health.  For example, the descriptor for the range 91-100 is 
‘Superior functioning in a wide range of activities, life’s problems never seem to get out of 
hand, is sought out by others because of his many positive qualities. No symptoms.’ (First et 
al., 2002). 
 
4.6.2 Conduct disorder, antisocial personality disorder and psychopathy 
4.6.2.1 Conduct disorder and antisocial personality disorder 
Conduct disorder (CD) and antisocial personality disorder (ASPD) were assessed using the 
Structured Clinical Interview for DSM-IV Axis II disorders (SCID-II) (First et al., 1997).  DSM-IV 
requires the presence of some symptoms of CD in childhood or adolescence in order for a 
later diagnosis of ASPD to be made, in SCID-II this is operationalized as two symptoms of CD 
needing to be present to allow a diagnosis of adult ASPD to be made.  However, three CD 
symptoms are needed for CD to be diagnosed itself (First et al., 1997).  Therefore, in this 
study two symptoms of CD allowed an adult diagnosis of ASPD to be made but three 
symptoms were required for a retrospective diagnosis of CD to be made. 
 
4.6.2.2 Psychopathy 
The Psychopathy Checklist Screening Version (PCL:SV)  (Hart et al., 1995) is a psychopathy 
screening tool which is robustly related to the full Psychopathy Checklist Revised (PCL-R) 
(Guy and Douglas, 2006).  The PCL:SV was scored on the basis of an interview with the 
participant and review of their medical records.  The PCL:SV has 12 items rated 0 (not 
present), 1 (possibly present), or 2 (definitely present), giving a total possible score of 24.  The 
usual cut-off score for psychopathy is 18 (Guy and Douglas, 2006).  I have received the 
necessary training to use the PCL-R and PCL:SV.   
 
4.6.3 Alcohol and drugs 
Lifetime substance use disorders were diagnosed using the SCID-I, which considers abuse 
and dependence on alcohol and various illicit drugs.  An additional study specific 
questionnaire was designed to obtain more detailed information about substance use and how 
it may relate to violent behaviour (see appendix B).  A bespoke questionnaire was employed, 
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rather than an existing one, because the questionnaires used in previous studies were to 
screen for substance misuse, whereas we could make a definitive diagnosis of such using the 
SCID-1.  Therefore, the additional questions were to focus on use of substances in 
adolescence (to explore the potential relationship with conduct disorder and violence in line 
with my hypotheses) and any associations between substance misuse and violent behaviour.  
Our questionnaire included questions about the age of onset of use of each substance; the 
frequency of use before the age of 15 and before 18, and at its peak usage; and the quantity 
of the substance consumed at its peak usage.  It also asked about whether participants had 
committed an alcohol or drug-related offence (e.g. drunk and disorderly or possession of 
drugs), whether they had stolen to buy the substance, whether they had ever been violent 
whilst intoxicated or whether they had been the victim of violence when intoxicated.  In 
addition, the medical records of patient participants were reviewed for information regarding 
substance misuse. 
 
4.6.4 Childhood adversity 
The Childhood Experiences of Care and Abuse Questionnaire (CECA-Q) (Bifulco et al., 2005) 
rates retrospective reports of childhood maltreatment.  It is reliable in individuals with psychotic 
disorders (Fisher et al., 2011).  A briefer modified version of the CECA-Q was employed 
(Hepgul et al., 2012), in order to keep the overall duration of the assessment battery to a 
manageable length for participants.   
 
4.6.5 Other clinical information 
4.6.5.1 Demographics 
Basic demographic information was obtained from participants including age, ethnicity, age of 
leaving full-time education and current employment status.  For patients their Mental Health 
Act status and current placement were noted. 
 
4.6.5.2 Family history of mental disorder  
The Family Interview for Genetic Studies (FIGS), a structured instrument that gathers 
diagnostic information on patients’ relatives (Maxwell, 1992) was conducted with all 




4.6.5.3 Illness course  
Past psychiatric history was obtained from the medical records including, age of illness onset, 
number and duration of hospital admissions and medication history.  Specific information 
required to determine treatment resistance or remission was also collected from the patients’ 
notes.   
 
Remission was defined as no symptomatic relapses for a period of six months and the 
following PANSS items scored as mild (3) or less (Andreasen et al., 2005): 
 Delusions (P1) 
 Conceptual disorganization (P2) 
 Hallucinatory behaviour (P3) 
 Blunted affect (N1) 
 Social withdrawal (N4) 
 Lack of spontaneity (N6) 
 Mannerisms/posturing (G5) 
 Unusual thought content (G9) 
 
Treatment resistance was determined using the modified Kane criteria (Conley and Kelly, 
2001), adapted for use with the PANSS: 
 At least two prior antipsychotic trials of 4-6 weeks duration at 400-600mg/day 
chlorpromazine equivalents with no clinical improvement 
 Persistence of illness for more than 5 years with no period of social or occupational 
functioning 
 Persistent psychotic symptoms assessed with PANSS as a score of moderate or 
greater on at least one of the positive psychotic symptom items (P items) 
 
4.6.5.4 Medication 
Patients’ antipsychotic medication at the time of the assessment was converted to 
chlorpromazine equivalents using the best available data (Gardner et al., 2010) to allow 




4.7 Assessment of violence 
4.7.1 MacArthur Community Violence Instrument 
All participants were asked about violent behaviour based on the MacArthur Community 
Violence Instrument (Steadman et al., 1998).  It assesses whether the participant has: 
 Thrown something at anyone 
 Pushed, grabbed, or shoved 
 Slapped 
 Kicked, bitten or choked anyone 
 Hit anyone with a fist, object or beaten anyone 
 Physically forced someone to have sex against their will 
 Threatened anyone with a weapon 
 Used a weapon 
Participants indicated how many times over their adult lifetime they had engaged in each type 
of aggressive behaviour and whether in the last six months they had perpetrated, or been a 
victim of, each behaviour.  Collateral information about lifetime violent behaviour in each 
category was obtained from medical records (for patients), and family informants where 
available for all participants.    
 
Responses to the question about forcing someone to have sex were not included in the 
analyses as this was a study of nonsexual violence, rather than sexual violence.  Previous 
research suggested that disaggregating items on the MacArthur Community Violence 
Instrument (MCVI) into their component parts may improve measurement, particularly the 
question ‘Have you kicked, bitten, or choked anyone?’ as it appears to be a complex item 
containing disparate violent acts (Michie and Cooke, 2006).  Therefore this question was split 
into three separate questions about each aggressive behaviour (kicking, biting and choking) 
for this study and analysed accordingly.  The MCVI can assess both recent (Steadman et al., 
1998) and lifetime violence (Michie and Cooke, 2006).  When the aggressive behaviour has 
occurred frequently during a participant’s adult life it can be difficult to assign this an exact 
frequency, this was noted in the development of the Life History of Aggression tool and led to 
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the following scale being used for measuring the frequency of aggressive behaviours (Coccaro 
et al., 1997): 
0 = never happened 
1 = only happened once 
2 = happened a couple or a few times (e.g. 2-3) 
3 = happened several times (e.g.4-9) 
4 = happened many times (e.g. 10+) 
5 = happened so many times that I couldn’t give a number 
Therefore, in this study, the above scale was used for each of the aggressive behaviours in 
the MCVI to allow categorisation of frequencies and comparison of these. 
 
4.7.2 Additional questions 
4.7.2.1 Most violent act 
Participants identified their most serious violent act, answering the following questions: 
 What is the most violent thing you’ve ever done? 
 Why did you behave that way? 
 What was the effect on you? 
 What was the effect for others? 
 Who was to blame? 
This information was used to determine whether the violent act was reactive or instrumental in 
nature. 
 
4.7.2.2 Forensic history 
Participants were asked about any history with the criminal justice system and if so, the nature 
of that contact (arrest, charge, caution, conviction and any sentence received).  
 
4.7.2.3 Family forensic history  
Participants and family informants were asked about a family history of violent behaviour and 
criminal convictions (including non-violent offences) and any associated sentences. They were 
also asked about other violence not investigated by the police, including domestic violence 




4.7.3 Gunn Robertson Violence Scale 
In the MacArthur Violence Risk Assessment Study (Steadman et al., 1998), aggressive acts 
were divided into two categories for analyses: violence (battery that resulted in physical injury, 
sexual assaults, assaultive acts that involved the use of a weapon, or threats made with a 
weapon in hand) and other aggressive acts (battery that did not result in physical injury).  In 
this study we sought to utilise a scale that captured broader descriptive data on each subject’s 
propensity to violence and selected the Gunn Robertson Violence Scale (see chapter 3). 
 
A criminal profile was devised based on nine types of offending behaviours, with scales for 
fraud, motoring, drink, relationship to drinking, drugs, financial gain, violence, sex and theft 
(Gunn and Robertson, 1979).  The violence scale incorporates aspects of several facets of 
violence including severity, victim injury, and frequency.  Ratings are made on a five point 
anchored scale (0-4), incorporating the offence itself, the consequence to the victim, and legal 
consequences for the perpetrator.  As detailed in chapter 3, ratings are given as follows: 
0 = No convictions.  Never gets into fights 
1 = No convictions. Evidence of minimal violence, i.e. occasional fights or damage to property 
2 = One or two convictions for violence, or repeated acts of violence to person or property, 
none of which has caused serious damage to life or health 
3 = Three or more convictions for violence 
4 = One or more severely violent episodes in which someone’s life or health has been 
seriously damaged 
 
Each participant was rated using the Gunn Robertson Violence Scale (GRVS) based on their 
lifetime history of offending, using information from the MCVI and other collateral information.   
 
4.7.4 Buss Perry Aggression Questionnaire 
The Buss Perry Aggression Questionnaire (BPAQ) is a self-report measure of aggressive 
attitudes and a trait measure of individual differences in aggressive tendencies (Buss and 
Perry, 1992) that has been used widely in studies of violence among patients with a mental 
disorder (Krakowski and Czobor, 2012, Hoptman et al., 2010).  The BPAQ consists of twenty-
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one items rated by participants on a five point scale, where 1 is extremely uncharacteristic of 
the participant and 5 is extremely characteristic of them.  The items are divided into four sub-
scales: physical aggression (e.g. If somebody hits me, I hit them back), verbal aggression (e.g. 
I often find myself disagreeing with people), anger (e.g. I have trouble controlling my temper) 
and hostility (e.g. When people are especially nice to me I wonder what they want); which can 
be summed for a total score. 
 
4.7.5 Official records 
4.7.5.1 Medical records 
Patients gave informed consent for access to their medical records.   Records were examined 
to determine the frequency of aggressive behaviours (using the categories of the MacArthur 
Community Violence Interview as above) and any documentation relating to their most serious 
violent incident or criminal offences. 
 
4.7.5.2 Police National Computer records 
All participants were asked for their permission to obtain information about them held by the 
Ministry of Justice on the Police National Computer (PNC).  This included data about any 
cautions or convictions received and sentences imposed.  Permission to access PNC records 
for the study participants was obtained from the Association of Chief Police Officers Criminal 
Records Office (ACRO) in April 2011.  Once recruitment of participants had been completed, a 
data sharing agreement was drawn up with the Ministry of Justice to ensure the safe sharing 
of this confidential information.  Unfortunately, this process was ultimately unsuccessful (see 
table 4-1). 
 
Table 4-1 Timeline showing process attempting to obtain permission to Police National 














 April 2011 Information provided to National Policing Improvement Agency about 
our information security procedures 
19
th




 May 2011 Data supply template provided by person A, Justice Statistics 
Analytical Services (JSAS), MoJ.  They informed us that all PNC data 
will be provided in one complete list at the end of the study.  
2011 - 2013 Data collection for study 
2
nd
 July 2013 Discussion with person B (Head of Data Improvement, Analysis and 
Linking, JSAS, MoJ) who stated that the permission granted in 2011 
was no longer sufficient as the process had changed.  Therefore he 
provided us with a data sharing agreement template to complete. 
27
th
 September 2013 Draft data sharing agreement sent to Legal Compliance Manager, 
King’s College London 
4
th
 November 2013 Approval of data sharing agreement received from Legal Compliance 
Manager, King’s College London 
14
th
 November 2013 Draft data sharing agreement sent to person B 
3
rd
 January 2014 Revised agreement and questions received back from person B 
17
th
 January 2014 Revised version sent back to person B 
10
th
 February 2014 Further queries received from person B  
21
st
 February 2014 Responded to say they would send the data sharing agreement to 
their legal department 
March – August 2014 No response to emails to person B 
30
th
 September 2014 Emails to various other people in JSAS as no response from person 
B for several months but received no responses 
24
th
 October 2014 Called MoJ switchboard and then email received from Justice Data 




 October 2014 Email from person C (Statistician, MoJ) apologizing that the request 
had ‘slipped through the net when person B left’. They agreed to 
send on to their legal team for comments.  
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November 2014 – 
March 2015 
No response to emails to person C 
9
th
 April 2015 Email from person D, Head of Data Improvement, Analysis and 
Linking team, JSAS to say that person C is currently on maternity 
leave and it ‘looks like this has slipped through the cracks again’.   
10
th
 April 2015 Data sharing agreement and accompanying information send to 
person E (PNC Statistics Team) 
13
th
 April 2015 Request from person E for more information about why PNC data is 




 April 2015 Request for further information about the study protocol and 
recruitment.  This was provided.  
29
th
 May 2015 Email from person E to state that the MoJ legal team were not 
satisfied that the PNC data was necessary/essential for the project 




All participants were given a full description of the study’s aims and design, and provided their 
written informed consent to take part.  They were interviewed over at least two sessions, to 
complete the clinical assessments (approximately one and a half hours), and the 
neuropsychological and cognitive batteries (two to three hours with a colleague SH).  
Participants were given breaks as necessary.  All interviews for in-patients were carried out on 
the patient’s ward; for out-patients, the interviews were conducted at their out-patient clinic or 
at St Andrew’s Hospital.  All healthy controls were assessed at St Andrew’s Hospital in 
Northampton.  Ethically approved procedures were in place in case of unanticipated 
disclosures.   
 
Participants were also asked to provide a urine sample for an illicit drug screen and have an 
MRI brain scan (lasting approximately 1 hour at Three Shires Hospital, Northampton).  Where 
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consent was given, a family member was also contacted to provide collateral information.  All 
participants were financially reimbursed (up to £55) for their time. 
 
4.9 Statistical analyses 
Statistical analyses were conducted using SPSS 18.  All measures were assessed for 
normality.  Where data were not normally distributed, or did not fit the assumptions for 
parametric analysis, non-parametric test equivalents were used.  A significance level of 
p<0.05 was adopted throughout.   
 
4.9.1 Between group comparisons 
In order to test for differences between the patient and control groups for demographic and 
clinical variables, t-tests, Mann-Whitney U and chi-square analyses were used.   
 
4.9.2 Analysis of violence  
Ordinal logistic regression was used to determine whether measures were statistically 
significant predictors of violence in the patient group.  These analyses were only conducted in 
the patient group due to the low levels of violence among control participants.  The ordinal 
logistic regression was based on the proportional odds model, which assumes that the effect 
of the independent variable is the same for all splits of the categories of the outcome variable.  
The parameters of the proportional odds model represent the odds ratios of being in the 
highest categories compared to the lowest categories.  For example, with the five outcome 
categories of the GRVS, and a single independent variable, then the odds ratio represents the 
combined comparison of outcome: category 4 with categories 3, 2, 1 and 0; categories 4 and 3 
with categories 2, 1 and 0; categories 4, 3 and 2 with categories 1 and 0; categories 4, 3, 2 
and 1 with category 0.   
 
4.9.3 Co-linearity 
Due to most variables not being normally distributed, Spearman’s correlations were calculated 




4.9.4 Effect size 
Odds ratios were calculated where appropriate, as it is widely recommended to report effect 
sizes even where results are not statistically significant. 
 
4.9.5 Mediation analyses 
Mediation analyses were carried out by testing the necessary triangle associations: statistically 
significant relationship between 1) independent and dependent variable; 2) independent and 
hypothesized mediator variable; 3) mediator and dependent variable.  Substantial attenuation 
in magnitude of effect of the association between independent and dependent variable after 







Chapter 5 Conduct Disorder and Quantification of Violence 
 
5.1 Abstract 
This chapter characterizes the study sample, assesses the validity of the Gunn Robertson 
Violence Scale to measure violence and considers the role of conduct disorder in lifetime 
violent behaviour among men with schizophrenia.  The results demonstrate that the GRVS 
has good construct validity and reasonable concurrent validity.  Conduct disorder, antisocial 
personality disorder and Psychopathy Checklist Screening Version score are all associated 
with the Gunn Robertson Violence Scale after controlling for substance use disorders.  Those 
patients with pre-morbid conduct disorder more frequently engaged in all types of violent 
behaviours assessed, apart from choking, indicating conduct disorder is a significant factor 
influencing later propensity to violence.  Aggressive attitudes were not associated with 
violence after relevant adjustments, either in all participants or the patient group only.  
However, pre-morbid conduct disorder was associated with aggressive attitudes in adulthood, 
apart from the hostility sub-scale which was associated with current psychotic symptoms.  
Instrumental violence was associated with higher psychopathy score. 
 
5.2 Background 
Our systematic review in chapter 3 (Harris et al., 2013), led to the selection of the Gunn 
Robertson Violence Scale (GRVS) as the method of quantifying violence in this study.  The 
GRVS was selected on the basis of three primary strengths: firstly, it incorporates data on both 
criminal justice interventions as well as self-reported violent incidents that remain undetected 
by the police or courts; secondly, that it considers severity, frequency and impact of violence; 
and finally, that several categories of violence (rather than dichotomous categories) could be 
utilized in the analyses.  
 
Traditionally, two forms of violence have been described, reactive and instrumental, although it 
is increasingly recognised that many individuals have a mixed pattern of violence (Dolan, 
2010).  Reactive violence is seen as provoked by a situation and is often emotionally charged.  
Instrumental violence is a premeditated means of obtaining a goal and is proactive rather than 
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reactive (Anderson and Bushman, 2002).  Psychopathy is particularly associated with 
instrumental violence (Gregory et al., 2012), while ASPD may be more associated with 
reactive violence (Dolan, 2010).  Instrumental violence occurs in some patients with 
schizophrenia and is usually associated with co-morbid psychopathy (Bo et al., 2011).  
Although interestingly, violence in the context of hallucinations and delusions can also 
sometimes be considered as instrumental (Felthous, 2008). 
 
The literature relating to schizophrenia and violence and premorbid CD, co-morbid ASPD and 
psychopathy, is reviewed in section 2.4.  To recap, CD is over-represented in patients with 
schizophrenia (Hodgins et al., 2008, Kim-Cohen et al., 2003) and is associated with an 
increased risk of violent behaviour (Arseneault et al., 2000, Hodgins et al., 2008, Swanson et 
al., 2008).  People with ASPD and schizophrenia also have an increased risk of violence 
(Volavka, 2014, Bo et al., 2013).  Psychopathy among those with schizophrenia is associated 
with lifetime violence and other criminal offending (McGregor et al., 2012, Tengström et al., 
2004, Tengström et al., 2000).   
 
Exploration of the relative importance of state versus trait factors in violence in schizophrenia 
is longstanding (Cheung et al., 1997a).  The Buss Perry Aggression Questionnaire (BPAQ) is 
a trait measure of individual differences in aggressive tendencies (Buss and Perry, 1992) that 
has been used widely in studies of violence among patients with a mental disorder (Krakowski 
and Czobor, 2012, Hoptman et al., 2010).  Anger has been described as the bridge to the 
verbal and physical aggression sub-scales of the BPAQ (Buss and Perry, 1992) and anger 
has consistently been shown to be associated with violence in the general population 
(Anderson and Bushman, 2002).  Aggressive traits are a feature of CD (Blair et al., 2014) and 
it is possible that these remain longstanding into adulthood.  Therefore trait aggression may 
differ in patients with schizophrenia on the basis of premorbid CD. 
 
It has been suggested that the presence of CD is a crucial contributory factor in a typology of 
adult patients with schizophrenia who behave violently (see chapter 2).  Violence among 
patients with schizophrenia may follow at least two distinct pathways, one associated with 
premorbid conditions, including CD, and another linked with the acute psychotic symptoms of 
schizophrenia (Volavka, 2014, Bo et al., 2011, Volavka and Citrome, 2011, Hodgins et al., 
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2014, Van Dongen et al., 2014, Van Dongen et al., 2015).  Therefore, this study specifically 
grouped patients on the basis of pre-morbid CD, in order to explore any differences between 
patients with schizophrenia, with and without pre-morbid CD, and how this affected their 
lifetime propensity to violence.  
 
5.3 Hypotheses 
This chapter will test the following hypotheses among men with schizophrenia: 
1) The Gunn Robertson Violence Scale (GRVS) is a valid measure of lifetime propensity 
to violence  
2) There is a cumulatively greater propensity for violence associated with: 
a. Each additional symptom of conduct disorder (CD)   
b. Each additional symptom of antisocial personality disorder (ASPD)  
c. Each additional item score of the Psychopathy Checklist Screening Version 
(PCL:SV)  
3) More aggressive attitudes are associated with a greater propensity for violence  
4) CD before the age of fifteen years old is associated with having more aggressive 
attitudes as an adult 
5) Instrumental violence is associated with co-morbid psychopathy 
 
5.4 Specific methodology 
The general methodology is described in chapter 4, methodology relating specifically to this 
chapter concerns assessing whether the GRVS is a valid measure of lifetime propensity to 
violence.  There are two main categories of validity used to assess a test or measure: content-
related validity and criterion-related validity.  Construct validity is a type of content-related 
validity and assesses whether the test or measure is related to underlying theoretical 
concepts.  Construct validity was assessed by analysing associations between the GRVS and 
other constructs with well-established associations with violence (conduct disorder, antisocial 
personality disorder, psychopathy, prison sentences).  Concurrent validity is a type of criterion-
related validity and assesses whether it is related to an existing similar measure.  Concurrent 
validity was tested by comparing the GRVS to the categories of severity of violence used in 
studies utilising the MacArthur Community Violence Instrument (MCVI), an established 
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benchmark measure.  These categories were violence (battery that resulting in physical injury, 
sexual assaults, assaultive acts that involved the use of a weapon, or threats made with a 
weapon in hand) or other aggressive acts (battery that did not result in physical injury) 
(Steadman et al., 1998).  All study participants were categorised using this method, in addition 
to the GRVS. 
 
5.5 Specific statistical analyses 
The general statistical analyses are described in chapter 4.  Due to the number of 
comparisons in the analyses in this chapter, corrections for multiple testing were undertaken 
using the Bonferroni Hochberg method (Hochberg and Benjamini, 1990), as it is more 
powerful than the standard Bonferroni method and usually results in a conservative p-value 
adjustment.  Both unadjusted and adjusted p–values are quoted.   
 
5.6 Results 
5.6.1 Inter-rater reliability 
A colleague (SH) and I (CO) each independently rated all participants, on the basis of all 
information obtained from the interviews, family members and medical records, using the 
GRVS criteria.  Inter-rater reliability was 89.4% across all participants.  In the eleven cases of 
disagreement, we reviewed and discussed the evidence to reach a consensus.  Differences in 
ratings, were principally due to differences in interpretation of the items, for example what 
constitutes ‘serious damage’ to health (rating = 4) and ‘occasional’ versus ‘repeated’ acts of 
violence (ratings = 1 and 2). 
 
5.6.2 Adjustment for confounders 
Age, ethnicity, Full Scale Intelligence Quotient (FSIQ) and current psychotic symptoms were 
considered as potential confounders based on the existing literature.  However, in this sample 
of patients with schizophrenia, there were no associations between violence and age, 
ethnicity, FSIQ or PANSS score (total or sub-scales).  Therefore, these variables were not 




A lifetime history of a substance use disorder was associated with lifetime propensity to 
violence (GRVS score) and so was included in all analyses.  Symptoms of CD and ASPD, and 
PCL:SV score were all independently associated with the GRVS score in this sample.  There 
was moderate correlation between symptoms of conduct disorder, symptoms of antisocial 
personality disorder and PCL:SV score as shown in the correlation table (see table 5-1), 
suggesting a degree of co-linearity.   
 
PCL:SV score was the most strongly associated with GRVS score, and was added to the 
regression model first.  In DSM-IV, prior CD symptoms are a pre-requisite for a diagnosis of 
ASPD, thus they were considered to be intimately related clinical constructs and only CD 
symptoms were entered into the regression models.  However, adding CD symptoms in 
addition to PCL-SV score to the models did not significantly improve the model fit.  Therefore, 




Ninety-three male participants were recruited for the study, fifty-four with schizophrenia and 
thirty-nine healthy controls with no history of any form of psychotic illness.  As per the study’s 
exclusion criteria, no participant had ever experienced a manic episode.  One patient met 
criteria for a co-morbid depressive episode at the time of the assessment and nine other 
patients had experienced a previous depressive episode.  Nine controls had a history of 
depression.   
 
The patients were recruited from the full spectrum of inpatient and outpatient mental health 
services and all of the healthy controls were living in the local community.  The ages of the 
participants ranged from eighteen to fifty-seven years old.  All of the healthy controls, apart 
from one, were from a white background.  Thirty-four of the patients were white British, six 
were white and black Caribbean, six were black Caribbean, five were Asian and three were of 
other ethnic backgrounds.   
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Table 5-1 Correlations with propensity to violence among patients (n=54) 
 























































































































































































































































Abbreviations: GRVS = Gunn Robertson Violence Scale; CD = conduct disorder; ASPD = antisocial personality disorder; PCL:SV = Psychopathy Checklist Screening Version; PANSS = 
Positive And Negative Syndrome Scale; FSIQ = Full Scale Intelligence Quotient
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5.6.4 Group comparisons of clinical characteristics 
The ages of the participants did not differ significantly between the groups but differences in key 
clinical characteristics were statistically significant (table 5-2).   Three patients and none of the 
controls met the PCL:SV threshold indicating psychopathy.  Six of the controls (15%) had a 
lifetime history of alcohol abuse and 1 had prior alcohol dependence.  Only three controls met 
criteria for prior cannabis abuse and six controls for lifetime cannabis dependence.  In terms of 
drugs other than cannabis, one control had prior cocaine abuse but there were no other 
instances of drug abuse or dependence among the controls.  Substance use disorders among 
the patients are shown in table 5-3. 
 
















t = -1.76 0.08 







t = 5.19 <0.001 







t = 6.86 <0.001 







 = 21.62 
(df=1) 
<0.001 




































t = -7.91 <0.001 





Table 5-3 Patients’ illness descriptors  








Number of hospital admissions 4.24 (5.41) 
 














Current dose of antipsychotic   
in chlorpromazine equivalent (mg) 
544.4 (427.86) 
Current location (n) 
Community 
Open/locked ward 
Low secure unit 






Mental Health Act status (n) 
Informal 








Conduct disorder (n) 24 (44%) 
 
Antisocial personality disorder (n) 21 (39%) 
 
Psychopathy Checklist Screening  
Version score 
6.91 (5.22) 
























Data reflects mean and (standard deviation) unless otherwise stated 
 
5.6.4.1 Clinical characteristics of patients 
Patients’ clinical characteristics are described in table 5-3.  All in-patients were detained under 
the Mental Health Act and nearly two thirds of the patients living in the community were subject 
to a Community Treatment Order.  Two patients had never been admitted to hospital.  Of the 
fifty-four patients, seventeen were prescribed an antidepressant and nineteen a mood stabilizer.  
One informal patient was not taking antipsychotics as suggested by his psychiatrist but all other 
patients were on antipsychotic medication.  Thirty-one patients (57%) were taking clozapine and 
could be considered clinically treatment resistant, but only eighteen (33%) had the 
compromised functioning and persistent psychotic symptoms necessary to meet the modified 
Kane criteria for treatment resistance (described in chapter 4).  Sixteen patients (30%) met 
criteria for remission (as outlined in chapter 4).   
 
5.6.4.2 Criminal convictions 
Forty of the fifty-four patients had a criminal conviction, thirty-one for more minor violence (e.g. 
common assault) and twenty-three for major violence (e.g. grievous bodily harm).  One patient 
had been convicted of murder, two of manslaughter and two of attempted murder.  Five patients 
had been convicted of common assault but another six reported committing assaults for which 
they were not charged.  Thirty-two patients had spent time in prison, with a mean of four periods 
in custody each and a mean duration in custody of twenty-two months, with a range between 0 
and 12 years.   
 
Among the controls there were relatively few instances of violence, with the most frequent 
incidents being common assault.  Only one of the controls had a criminal conviction, which was 




5.6.5 Group comparison of behaviours from the MacArthur Community Violence 
Instrument  
The patients had an increased lifetime frequency of all the types of aggressive behaviours 
compared to the controls, apart from pushing, grabbing or shoving (see table 5-4).  However, 
choking and slapping were no longer statistically significant after adjusting for multiple 
comparisons. 
 
Table 5-4 Comparison of behaviours from the MacArthur Community Violence Instrument 
(MCVI) between patients and controls 
Behaviour 
from MCVI 



























































1247.5 0.042 0.084 
Hit anyone 

























1623.5 <0.001 0.006 
a) Based on the 0-5 frequency scale of the Life History of Aggression (see 4.7.1 in chapter 4) 
 
 
5.6.6 Group comparison of Gunn Robertson Violence Scale ratings 
The distribution of Gunn Robertson Violence Scale ratings for both groups is shown in figure 5-
1.  The mean Gunn Robertson Scale rating for the patients was 2.41 and for the controls was 
0.59 (U=1835.5, p<0.001), demonstrating that the patients had a greater lifetime propensity to 
violence than the healthy controls.   
 
5.6.7 Validity of the Gunn Robertson Violence Scale as a measure of lifetime propensity 
to violence  
5.6.7.1 Construct validity 
Associations between the GRVS and other constructs with well-established associations with 
violence were analysed (table 5-5).  Due to the low levels of violence and conduct disorder in 
the control group, these analyses were restricted to the patient group.  Due to the low rate of 






Figure 5-1 Gunn Robertson Violence Scale (GRVS) ratings in patients and controls 
 
Table 5-5 Associations between GRVS and established variables associated with violence 
Variable Odds 
ratio 









































0 1 2 3 4
Number of 
participants 





5.6.7.2 Concurrent validity 
5.6.7.2.1 Severity of violence 
GRVS scores were compared with the categories used in studies utilizing the MCVI and this 
cross-tabulation is shown in table 5-6.  All GRVS scores of 4, and all but one scores of 3, would 
be categorised as violence.  GRVS scores of 1 and 2 were split between the categories of 
violence and other aggressive acts.   
 
Table 5-6 Comparison of GRVS scores with violence categories used in the MacArthur Violence 
Risk Assessment Study (1998)  
Gunn Robertson 
Violence Scale 
  No violence Other    
aggressive acts  
      Violence        Total 
0 2 2 0 4 
 
1 0 7 4 11 
 
2 0 4 10 14 
 
3 0 1 8 9 
 




5.6.7.2.2 Frequency of violence 
The above considers the severity of the violence, in order to try to assess the validity of the 
GRVS in relation to capturing frequency of violence, it was compared with frequency of one of 
the aggressive behaviours in the MCVI (use of a weapon was selected as this would capture 
the most severe forms of violent behaviour).  This is shown in table 5-7, which indicates that 













Table 5-7 Comparison of frequency scores for lifetime use of a weapon with GRVS scores 










0 24 0 0 0 0 0 24 
 
1 24 2 0 0 0 0 26 
 
2 10 4 3 1 0 0 18 
 
3 1 3 0 5 0 2 9 
 
4 1 4 5 3 1 2 16 
 
Total 60 13 8 9 1 2 93 
 




5.6.8 Conduct disorder, antisocial personality disorder and psychopathy and violence  
These analyses were conducted in the patients only due to the low levels of CD, ASPD and 
psychopathy in the healthy controls.  Twenty-four patients were diagnosed with prior CD, 
twenty-one with ASPD and three had a PCL:SV score indicating psychopathy.  After adjusting 
for substance use disorders, CD and ASPD were significantly associated with an increased 
GRVS score and the presence of each symptom of CD and ASPD was also associated with an 




























CD 5.24 1.61, 
17.04 
 
7.59 0.60 0.006 0.006 
CD symptoms  
 









1.87 1.31, 2.66 12.09 0.18 0.001 0.004 
PCL:SV score 
 
1.37 1.18, 1.58 17.59 0.07 <0.001 0.004 
 
a) Adjusted for the lifetime presence of a substance use disorder 
 






In terms of CD specifically, those with prior CD had more frequently engaged in all behaviours 
assessed by the MCVI, apart from choking, as shown in table 5-9.  These associations 
remained statistically significant after adjusting for multiple testing.   
 
 
Table 5-9 Comparisons of behaviours from the MacArthur Community Violence Instrument 
(MCVI) in patients with and without prior conduct disorder 
Behaviour from 
MCVI 




























































315.5 0.344 0.344 
Hit anyone with 






161.5 <0.001 0.004 
Threatened 






138.5 <0.001 0.004 







110.5 <0.001 0.004 
 
a) Based on the 0-5 frequency scale of the Life History of Aggression (see 4.7.1 in chapter 4) 
 
 
5.6.9 Aggressive attitudes  
5.6.9.1 All participants 
Higher total score on the Buss Perry Aggression Questionnaire (BPAQ) was associated with an 
increased propensity to violence (p=0.004) after controlling for substance use disorders, but this 
did not remain statistically significant after adjusting for psychopathy.  Therefore aggressive 
attitudes were not associated with an increased lifetime propensity to violence.  When 
considering the sub-scales of the BPAQ, verbal aggression and anger were not associated with 
propensity to violence after adjusting for substance use disorders. The hostility (p=0.04) and 
physical aggression (p<0.001) sub-scales were associated with violence after adjusting for 





5.6.9.2 Patients only 
On univariate analysis, higher total score on the BPAQ was associated with an increased 
propensity to violence (p=0.037) but this did not remain statistically significant after adjustments.  
In terms of the sub-scales of the BPAQ, both verbal aggression (p=0.025) and physical 
aggression (p=0.005) were associated with violence on univariate analyses but did not remain 
statistically significant after adjustments.  Anger and hostility sub-scales were not associated 
with violence. 
 
Prior CD was associated with increased aggressive attitudes in adulthood; total and sub-scale 
scores on the BPAQ in patients with, and without, prior conduct disorder (table 5-10).  The 
hostility sub-scale of the BPAQ is correlated with the P and G symptom scales and total score 
on the PANSS (table 5-11).    
 
 
Table 5-10 Comparisons of Buss Perry Aggression Questionnaire scores in patients with and 





















































Table 5-11 Correlations between PANSS and BPAQ among patients (n=54) 
 





































































































































































































Abbreviations: PANSS = Positive And Negative Syndrome Scale (sub-scales for Positive symptoms, Negative symptoms and General psychopathology); BPAQ = Buss Perry Aggression 




5.6.10 Instrumental violence 
For seven of the fifty-four patients (13%), their most serious act of violence during their adult life 
was instrumental in nature.  Six of these seven patients had pre-morbid CD and the patient 
without CD was the only one who did not have a GRVS score of 4.  The seven included all three 
patients in the sample who met the threshold indicating psychopathy (all three of whom had a 
GRVS score of 4).  The mean PCL:SV score of these seven patients with instrumental violence 
was 13.7 and the rest of the patients was 5.9 (t=4.25, p<0.001). 
 
5.7 Discussion  
This study has demonstrated that the GRVS has good inter-rater reliability, good construct 
validity and reasonable concurrent validity.  CD, ASPD and PCL:SV score are all associated 
with GRVS after controlling for substance use disorders.  Those patients with pre-morbid CD 
more frequently engaged in all violent behaviours assessed, apart from choking, indicating CD 
is a significant factor influencing later propensity to violence.  Aggressive attitudes measured by 
the BPAQ, were not associated with violence after relevant adjustments, either in all participants 
or the patient group only.  However, pre-morbid CD was associated with aggressive attitudes in 
adulthood, apart from the hostility sub-scale which was associated with current psychotic 
symptoms.  Instrumental violence was associated with a higher psychopathy score. 
 
5.7.1 Validity of the Gunn Robertson Violence Scale as a measure of lifetime propensity 
to violence 
The original paper describing the development of the Gunn Robertson Scale within a prison 
population (Gunn and Robertson, 1976), reported very good inter-rater reliability while the 
authors acknowledged the difficulties of assessing its validity.  In this study we also achieved 
good inter-rater reliability for the violence sub-scale of the Gunn Robertson Scale in a 
population of men with schizophrenia in a variety of mental health settings and healthy controls.  
Concurrent validity was considered by comparing the GRVS scores with the MCVI data, and 
construct validity by assessing associations between the GRVS and factors known to be linked 
to violence.  A modest degree of concurrent validity was found for both severity and frequency 




between the GRVS and other factors associated with the risk of violence, namely CD, ASPD, 
psychopathy and substance use disorders.   
 
This data suggests the GRVS has reasonable validity in this population.  The GRVS offers 
significant advantages over the practice of dichotomising subjects as violent or non-violent on 
the basis of an arbitrary threshold and it incorporates some indices of severity, frequency and 
outcome of the violence.  Therefore, we conclude that the GRVS is a good means of quantifying 
lifetime violence propensity amongst men with schizophrenia.   
 
The question in the MCVI ‘Have you kicked, bitten, or choked anyone?’ was disaggregated (see 
chapter 4) into the three separate behaviours (Michie and Cooke, 2006).  Choking and biting 
were relatively rare in this sample, both among patients and controls, while kicking was much 
more common.  Choking was the only behaviour which did not differ between patients with, and 
without, prior CD, although this could be a reflection of lack of power due to the low numbers 
who engaged in the behaviour.  The differences in the frequencies of these three behaviours 
would seem to support the benefit of disaggregating the question, potentially allowing the 
collection of richer information about seemingly different behaviours. 
 
Using the MCVI to score the GRVS reduces the detail available from the data but is an 
improvement in the quantification of violence compared to earlier studies which employed the 
MCVI but then classified participants only into ‘violent’ or ‘other aggressive acts’ categories 
(Steadman et al., 1998, Appelbaum et al., 2000, Swanson et al., 2006), as with the GRVS there 
are five categories of violence.  Michie and Cooke (2006) suggested a hierarchy of severity of 
behaviours in the MCVI, which could allow consideration of the individual MCVI behaviours as a 
more detailed overall measure of violence.  However, this approach is limited by the consequent 
need for a very large sample size, to give enough data for each individual aggressive behaviour, 
to allow meaningful statistical analyses.  Use of the GRVS may be more pragmatic but there is 
scope for further development of the scale.  For example, the GRVS score of 3 is based on 
number of convictions only and it would be preferable to also include an element of self-report 
like the other scores on the scale (Harris et al., 2013).  It would also be beneficial to research 





5.7.2 Conduct disorder, antisocial personality disorder, psychopathy and violence 
In this sample of men with schizophrenia, 44% had prior CD, a finding strikingly consistent with 
previous studies of those with severe mental illness (Hodgins et al., 2008, Kim-Cohen et al., 
2003).  It has been suggested that longitudinal, prospective studies are needed to understand 
why CD is more common among people with schizophrenia (Hodgins et al., 2008).  Both 
schizophrenia (Murray and Lewis, 1988) and CD (Blair et al., 2014) are neurodevelopmental 
disorders, where a combination of genetic and environmental factors interact to modify the 
normal trajectory of brain development and behaviour.  From an aetiological perspective one 
possible explanation for why CD is more common among people with schizophrenia than the 
general population, is that a proportion of genetic and environmental factors that influence the 
risk of developing each disorder are common between them.  For example, there is evidence 
that childhood physical abuse is more common in those who develop schizophrenia (Rosenberg 
et al., 2007) and is also more common among those with a history of CD (Afifi et al., 2011), 
leading to the hypothesis that physical abuse is important in the aetiology of both (Hodgins et 
al., 2008).   
 
Patients with prior CD, and those who went on to have ASPD, had an increased lifetime 
propensity to violence, compared to patients without prior CD.  This association was present at 
the level of the individual symptoms of these disorders, as it was for the PCL:SV score.  This 
finding highlights that even a few symptoms of CD in childhood or adolescence is associated 
with an increased likelihood of aggressive behaviour in adulthood.  This is in line with a previous 
study of men and women with severe mental illness (Hodgins et al., 2008) and one of men with 
schizophrenia or schizoaffective disorder (Hodgins et al., 2005), where the number of CD 
symptoms present prior to the age of 15 significantly increased the risk of violent crime after 
controlling for alcohol and illicit drug use.   
 
These results are relevant to clinical practice, showing it is important to carefully consider 
symptoms of CD, ASPD and psychopathy, even if full diagnostic criteria are not met, in order to 
inform a risk assessment.  As special training is required to administer the PCL:SV, the 




more easily.  Patients with prior CD can be easily identified at first presentation to mental health 
services by conducting the relevant interview, allowing them to be identified as a high risk group 
for behaving violently.  This would allow a structured package of interventions to be offered to 
address their aggressive behaviour, any co-morbid substance misuse and other relevant 
psychosocial deficits, with the aim of reducing the risk of violence.  Ideally, early intervention in 
childhood could reduce the risk of violence in adulthood.  Children with CD would be an 
important group to target in terms of violence prevention and there are effective treatments 
available for CD, particularly parenting training (Weisz et al., 2004, Scott, 2008). 
 
5.7.3 Aggressive attitudes 
The physical aggression, verbal aggression and anger sub-scales and total score on the BPAQ 
were all significantly higher in patients with prior CD.  This association with CD may contribute 
to the explanation of why BPAQ was no longer associated with propensity for violence after 
controlling for psychopathy.  A potential explanation for the lack of increased scores on the 
hostility sub-scale among those with CD is its correlation with the PANSS scores, suggesting 
the hostility score is associated with current psychotic symptoms.  It can certainly be seen that 
some items in the BPAQ could be descriptive of paranoid ideation, for example, ‘I sometimes 
feel that people are laughing at me behind my back’ (Buss and Perry, 1992). 
 
Anger has consistently been shown to be associated with violence in the general population 
(Anderson and Bushman, 2002).  Whilst the current study did not support this, there is  
evidence that trait anger is associated with violence in schizophrenia (Reagu et al., 2013, 
Nederlof et al., 2011).  However, an area of emerging importance in the literature, is the role of 
anger in response to psychotic symptoms as a possible mediator or correlate of the relationship 
between aggressive behaviour and psychotic symptoms in schizophrenia (Coid et al., 2013, 
Ullrich et al., 2014, Bucci et al., 2013, Reagu et al., 2013).  The interplay of trait anger, and state 






5.7.4 Instrumental violence 
There was a relatively low level of instrumental violence in this sample of men with 
schizophrenia.  This fits with only three patients meeting the threshold indicating psychopathy.  
All three of these patients used instrumental violence and had a GRVS score of 4 indicating the 
seriousness of the violence they had perpetrated.  As hypothesized, instrumental violence was 
associated with a higher PCL-SV score.  This is in keeping with the literature suggesting co-
morbid psychopathy is associated with a significantly increased risk of violence in schizophrenia 
(McGregor et al., 2012, Tengström et al., 2000, Tengström et al., 2004, Bo et al., 2011). 
 
5.8 Strengths and limitations 
5.8.1 Strengths 
The sample is well-defined and described, containing a range of both in-patients and out-
patients with varying levels of symptomatology and a range of histories of violence.  The 
participants underwent a comprehensive assessment of both their background history 
(generally and in relation to violence) and their mental disorders.  The use of the GRVS has 
allowed a more careful quantification of violence.  
 
5.8.2 Limitations 
As described in 4.7.5.2, it was not possible to obtain the Police National Computer records for 
study participants.  This meant that there was no method of confirming the details of convictions 
or cautions reported by participants or their family members.  For patient participants, their 
medical records were examined, which did provide further information from another source 
about any violent behaviour.  Multiple sources of information are desirable in order to ensure 
high quality, accurate information regarding any violent behaviour of the individual, and the 
inability to obtain PNC records resulted in a reduced number of sources of information.  
However, self-report of violence has been shown to be reliable and valid, with patients reporting 
five times more violent acts than those documented in official records (Steadman et al., 1998).  






This study is limited by its cross-sectional design, which does not allow temporal proximity 
between the measurement of the clinical variables and the violent behaviour.  A prospective 
methodology would allow this type of analyses but would require a very large sample and a long 
follow-up period due to the relative rarity of incidents of severe violence.  However, this chapter 
has considered the presence of relatively stable disorders (CD, ASPD, psychopathy) and the 
lifetime propensity to violence, so temporal proximity is less crucial.  It was not possible to test 
the contribution of CD only to lifetime propensity to violence, compared to CD progressing to 
ASPD, as there were only three patients in the sample with CD only.  This would be a useful 
focus for future research.   
 
In addition, none of the healthy controls in this study had a significant history of violence and 
this meant that analyses relating to violence were limited to the patient group.  It was not 
possible to compare violent participants with and without schizophrenia; in order to achieve this 
in future studies, it would be necessary to actively recruit control participants from criminal 
justice settings such as probation offices and prisons.   
 
5.9 Conclusions 
The GRVS is a useful method of quantifying violence in men with schizophrenia and appears to 
have good inter-rater reliability and validity.  CD prior to the age of 15 is important in 
determining the lifetime propensity for violence in men with schizophrenia.   This association is 
present at the level of individual CD symptoms and indicates that it would be useful to carefully 
assess these symptoms among patients presenting with schizophrenia to inform their risk 
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6.1 Introduction to published paper 
This paper examines the association between childhood adversity and propensity to violence in 
adulthood among men with schizophrenia.  The literature which informed the generation of the 
hypotheses described in this paper was outlined in section 2.6.  In summary, there is emerging 
evidence that childhood adversity, perhaps acting at critical periods of childhood development, 
is associated with conduct disorder, psychosis, and the risk of violence.  The methodology is 
described within the published paper and follows the same general methodology of the rest of 







































6.2 Conduct disorder as a mediator of the association between 
cumulative childhood adversities and violence  
The published paper above found that cumulative childhood adversities were associated with 
propensity to violence and this association may be mediated by CD.  A mediation model seeks 
to explain what underlies a relationship between an independent variable and a dependent 
variable by the inclusion in the model of a third variable (the mediator variable).  Rather than a 
direct causal relationship between the independent and dependent variable, a mediation model 
proposes that the independent variable influences the mediator variable (in this case CD 
symptoms), which in turn influences the dependent variable.   
 
The results in the paper show that cumulative childhood adversities were associated with 
propensity to violence (odds ratio 1.90).  CD symptoms were then added to the regression 
model as a co-variate, to explore whether CD symptoms were a mediator of this association.  
As shown in the brackets in figure 1 in the published paper, the association between childhood 
adversities and violence was then no longer statistically significant.  This substantial attenuation 
in the effect size of the association between childhood adversities and violence after co-
variation of the mediator variable (CD symptoms), was interpreted as evidence of an indirect 
pathway, rather than a direct causal relationship between childhood adversities and violence.  In 
other words, that childhood adversity via conduct disorder may be a pathway to violent 
behaviour in schizophrenia. This raises the question of whether CD and childhood adversities 
are part of complex interactions, possibly with other factors in childhood, which contribute to an 
increased propensity to violence in adulthood.  
 
6.3 Conclusions 
This is the first study to demonstrate that among men with schizophrenia, exposure to domestic 
violence in childhood is associated with an increased propensity to violence in adulthood.  
Symptoms of CD were associated with cumulative exposure to childhood adversities.  Conduct 
disorder may mediate the association between cumulative childhood adversities and adult 




interplay between CD, childhood adversity and later violence in schizophrenia.  There may be 





Chapter 7 Conduct disorder, substance misuse and propensity 
to violence in schizophrenia 
 
7.1 Abstract 
Substance misuse is an important factor associated with an increased risk of violent behaviour 
in patients with schizophrenia.  Pre-morbid conduct disorder is also a marker for those more 
likely to pose an adult risk of violence.  This chapter aimed to explore the relationships between 
conduct disorder and substance misuse in order to inform our model of the link between 
schizophrenia and violence.  Fifty-four male patients with schizophrenia were recruited from a 
broad range of inpatient and outpatient mental health services.  Symptoms of conduct disorder 
prior to the age of 15, use of alcohol and drugs, and adult violent behaviour were quantified. 
Patients with schizophrenia and pre-morbid conduct disorder began using alcohol and cannabis 
at an earlier age and more frequently than those without.  Those with pre-morbid conduct 
disorder also had higher rates of lifetime substance use disorders.  Pre-morbid conduct disorder 
and lifetime substance use disorders were both significantly associated with an increased 
propensity to violence in men with schizophrenia.  Both conduct disorder and substance use 
disorders play independent roles in the propensity to violence but also interact with each other.  
Conduct disorder and early substance misuse may be useful targets for early intervention to 
reduce the risk of future violence in schizophrenia. 
 
7.2 Background 
The literature relating to substance misuse and violence in schizophrenia has been reviewed in 
section 2.5.  To summarize, substance misuse is associated with violence both in the general 
population (Coid et al., 2006) and in those living with schizophrenia (Swanson et al., 2006), 
though controversy remains about the extent of its role in mediating the risk of violence in 
schizophrenia.  Some evidence shows that substance misuse is one of multiple factors that 
increase the risk of violent behaviour in patients with psychotic illnesses (Daffern et al., 2005, 
Harris et al., 2010, Stompe et al., 2004); while other data suggest that the increased risk of 




other factors (Elbogen and Johnson, 2009, Fazel et al., 2009).  Adding complexity to this 
debate, a reanalysis of data from one of these studies (Elbogen and Johnson, 2009) found that 
those with severe mental illness, irrespective of the presence of substance abuse, were 
significantly more likely to be violent than those with no mental illness (Van Dorn et al., 2012), a 
finding later confirmed specifically for schizophrenia (Short et al., 2013).  In short, it is now 
generally accepted that there is an increased risk of violence in schizophrenia, independent of 
co-morbid substance misuse, though substance misuse is associated with a further increase in 
that risk.     
 
The nature of the link between schizophrenia, substance misuse and violence may involve a 
complex interaction with other vulnerabilities, such as pre-morbid conduct disorder (CD).  CD 
reflects a pattern of early life persistent antisocial behaviour that begins before the age of 15, 
symptoms include: initiating physical fights; forcing someone into sexual activity; being 
physically cruel to animals; deliberately destroying others’ property; fire-setting with the intention 
of causing serious damage (First et al., 1997).  Substance misuse is itself not a diagnostic 
criterion for CD, though CD is associated with an increased risk of substance abuse (Blair et al., 
2014) and an increased risk of starting to use all classes of substances before the age of 18 
(Hopfer et al., 2013).  Furthermore from a developmental perspective, CD is over-represented in 
the childhood histories of patients who later develop schizophrenia (Hodgins et al., 2008, Kim-
Cohen et al., 2003) and finally is then associated with an increased risk of adult violent 
behaviour (Arseneault et al., 2000, Hodgins et al., 2008, Swanson et al., 2008).  It may be that 
substance misuse is more common in patients with schizophrenia with pre-morbid CD (Hodgins 
et al., 2005).  Furthermore it is not clear if these links are somehow aetiologically connected 
through childhood or adolescence, or are merely external behavioural markers at each 
developmental stage of those patients with schizophrenia who will be more violent as adults. 
 
7.3 Hypotheses 
It was hypothesised that among patients with schizophrenia and pre-morbid CD, compared to 




1) use of alcohol and drugs at an earlier age 
2) a greater frequency of alcohol and drug use before adulthood 
3) higher rates of lifetime substance use disorders which would then be associated with an 
increased propensity to violence.  
 
7.4 Specific methodology 
The methodology is described in chapter 4 and the additional questionnaire utilized to obtain 
information about alcohol and drug use is appendix B.  The Structured Clinical Interview for 
DSM-IV Axis I disorders (SCID-I) (First et al., 2002) was used to diagnose misuse of alcohol 
and drugs.  The fourth edition of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV) categorizes ‘substance use disorders’ as either abuse or dependence (American 
Psychiatric Association, 2000).   
 
7.5 Results 
7.5.1 Sample characteristics 
The demographics of the patient group are as described in chapter 5; all patients took part in 
this component of the study. 
 
7.5.2 Associations with violence 
There was no association between age, ethnicity or current psychotic symptoms and lifetime 
propensity to violence (GRVS score).  CD (OR=5.24, CI 1.61-17.04, p=0.006), ASPD (OR=5.57, 
CI 1.70-18.19, p=0.004) and PCL:SV score (OR=1.37, CI 1.18-1.58, p<0.001) were all 
associated with violence.  There was moderate correlation between symptoms of CD, and 
ASPD, and PCL:SV, suggesting a degree of co-linearity entirely consistent with their clinical 
constructs.  Therefore, PCL:SV score was included in the models as it was the most strongly 
associated of the three variables with violence propensity rated on the GRVS score.  The earlier 
analyses in chapter 6 identified that cumulative childhood adversity was associated with 





7.5.3 Substance use disorders and conduct disorder 
7.5.3.1 Age of onset and frequency of early use 
Patients with schizophrenia and pre-morbid CD, compared to those without pre-morbid CD, first 
used alcohol at an earlier age (12.1 years vs 15.1 years, U=512.50, p=0.001).  Cannabis (but 
not other drugs) use also started younger in the CD group (13.26 years vs 15.53 years, 
U=308.00, p=0.023).  CD was also associated with a greater frequency of alcohol and cannabis 
use both before the age of 15 and between 15 and 18 years old (table 7-1 and figures 7-1, 7-2, 
7-3 & 7-4).   
 
Table 7-1 Comparison of frequency of alcohol and cannabis use in those with and without pre-
morbid conduct disorder 


















Cannabis before 15 years old 16.72 
(df=4) 
0.002 














































































































7.5.3.2 Lifetime history 
There were also higher rates of lifetime substance use disorder (SUD) in the patients with pre-
morbid CD (table 7-2).  All the patients with pre-morbid CD had at least one lifetime SUD (96% 
had an alcohol use disorder and 92% had a drug use disorder).  Of those without CD, 63% had 
a lifetime history of a SUD (43% had an alcohol use disorder and 53% had a drug use disorder).  
Patients with CD were more likely to use more types of drugs (4.33 drugs vs 1.80 drugs, U=134, 
p<0.001). 
 
Table 7-2 Lifetime history of substance use disorders and pre-morbid conduct disorder 














Alcohol use disorder 23 13 16.54 <0.001 
 
Cannabis use disorder 22 16 9.40 0.002 
 
Cocaine use disorder 16 5 14.03 <0.001 
 
Opioid use disorder 11 1 13.93 <0.001 
 
Stimulant use disorder 
 
11 3 8.92 0.003 
 
 
7.5.4 Substance misuse, conduct disorder and violence 
Conduct disorder was significantly positively associated with propensity to violence after 
adjusting for lifetime SUD and cumulative childhood adversity (OR=3.89, 95%CI 1.14-13.28, 
p=0.03).  Of the 16 patients who had the greatest lifetime propensity to violence (GRVS score of 
4), pre-morbid CD was present in 75% and a lifetime history of SUD in 100%.  Of the 4 patients 
who had the lowest lifetime propensity to violence (GRVS score of 0), none had pre-morbid CD 
or a lifetime history of SUD.  Of the 11 patients without pre-morbid CD or SUD, all had low 





A history of an alcohol related arrest was strongly associated with an increased propensity to 
violence (OR=8.12, 95% CI 2.10-31.43, p=0.002).  Twenty-three participants (43%) reported 
behaving violently when under the influence of alcohol and 20 (37%) said they had been the 
victim of violence when drunk.  In the whole group, a lifetime history of a SUD was associated 
with an increased propensity to violence, after adjusting for PCL:SV score and cumulative 
childhood adversity (OR=6.54, 95%CI 1.13-37.79, p=0.036).  When considered separately, 
there was a trend between alcohol use disorders and propensity to violence (p=0.071) but not 
for drug use disorders. 
 
The relationship between SUD and violence was assessed in groups with and without pre-
morbid CD.  All of the patients with CD had a lifetime history of SUD and so SUD did not 
distinguish those with a greater or lesser propensity to violence.   In the group without CD, 
lifetime SUD was still associated with GRVS, after adjusting for PCL:SV score, (p=0.036) but 
this was only a trend after also adjusting for cumulative childhood adversity (p=0.061). 
 
7.6 Discussion 
This study of men with schizophrenia has shown that patients with pre-morbid CD had higher 
rates of lifetime SUD and began using alcohol and cannabis earlier and more frequently and 
used a wider variety of drugs.  A lifetime history of SUD was associated with an increased 
propensity to violence.  A trend remained between SUD and violence when I considered only 
the group of patients who did not have pre-morbid CD, suggesting the importance of SUD in 
violence even in the absence of CD.  In addition, CD was associated with an increased 
propensity to violence, after adjusting for SUD.  These findings confirm that both CD and SUD 
are independently associated with an increased risk of violence in schizophrenia.   
  
7.6.1 Substance use disorders and conduct disorder 
Cannabis use is associated with the subsequent development of psychotic symptoms and 




association (Zammit et al., 2002, Arseneault et al., 2004, Di Forti et al., 2015).  Cannabis use in 
early adolescence is more strongly associated with experiencing symptoms of schizophrenia in 
adulthood than use in late adolescence (Arseneault et al., 2002).  It has also been suggested 
that CD symptoms may independently increase the likelihood of cannabis use, which in turn 
increases the risk of psychosis (Malcolm et al., 2011).   
 
In this study patients with schizophrenia and pre-morbid CD began using alcohol and cannabis 
at an earlier age and with greater frequency than those without pre-morbid conduct disorder.  
This is consistent with evidence that among patients with a first episode of psychosis, the 
number of CD symptoms is linked to exposure to cannabis at a younger age (Malcolm et al., 
2011).  Also, in patients with schizophrenia, a history of CD is associated with an earlier age of 
onset and more severe symptoms of substance abuse (Mueser et al., 1997, Fulwiler et al., 
1997).  Patients with pre-morbid CD in this study also had an increased rate of lifetime SUD, 
which fits with previous evidence (Mueser et al., 2006). 
 
7.6.2 Substance use disorders, conduct disorder and violence 
Our finding that CD present before the age of 15 is associated with an increased propensity to 
adult violence, after adjusting for lifetime SUD, is in keeping with the results of earlier studies 
(Hodgins et al., 2005, Hodgins et al., 2008).  This highlights the importance of considering pre-
morbid CD in the association between schizophrenia and violence, independently of alcohol and 
illicit drug use.  However, it is clear that lifetime substance misuse is also crucially important 
independent of CD.  In this sample, a lifetime history of a SUD was associated with an 
increased propensity to violence in schizophrenia, and there was also a trend towards this when 
considering only those patients who did not have pre-morbid CD.  Therefore, both CD and SUD 
independently increase the propensity to violence. 
 
Earlier studies have shown an association between current alcohol abuse and violence in first 




psychosis have found previous drug (but not alcohol) misuse was associated with aggression 
(Dean et al., 2007, Harris et al., 2010, Fazel et al., 2014, Langeveld et al., 2014).  However, 
although all of these studies considered past offending, none assessed CD or ASPD.  We have 
shown that pre-morbid CD is associated with an increased risk of lifetime drug use disorders.  It 
is therefore possible that CD is influencing the association between drug use and violence 
found in those studies (which did not assess CD).  Indeed it has been demonstrated that 
individuals with cannabis dependence are more likely to be violent and this association was 
best explained by a history of conduct disorder (Arseneault et al., 2000).   
 
CD occurring prior to the onset of psychosis has an effect both on risk of substance abuse and 
the risk of violence, both individually and more speculatively additively. Therefore, it is important 
to consider the role of CD in future studies of substance misuse and violence in schizophrenia 
due to its associations with both.   
 
7.6.3 Early risk factors for violence 
Early use of substances in patients with schizophrenia and pre-morbid CD is important in the 
risk of later violent behaviour.  Substance abuse that begins very early on among people who 
later developed serious mental illness was associated with a greater risk of violence than 
substance abuse that began in adulthood (Fulwiler et al., 1997).  Among those with severe 
mental illness, age of onset of substance abuse predicted violence after controlling for CD 
(Fulwiler and Ruthazer, 1999).  This emphasises the importance of early onset of substance 
misuse in relation to later violent behaviour and hence the importance of early intervention to 
treat substance abuse and CD with the target of reducing the risk of future violence.  Effective 
treatments are available for CD, particularly parenting training (Weisz et al., 2004, Scott, 2008).  
In addition, there are also well-established treatment programmes for adolescent substance use 
disorders (Hogue et al., 2014).  However, co-morbid CD is known to reduce the effectiveness of 





Understanding the early influences on the complex trajectory towards violence is crucial in order 
to reduce the risk of future violence.  It is clear that CD increases the likelihood of cannabis use 
in early adolescence, which increases the risk of schizophrenia.  Whilst there is an independent 
increase in the risk of violence associated with schizophrenia, pre-morbid CD and lifetime SUD 
are also associated with increases in the propensity to violence.  Future prospective studies 
would benefit from focusing on the nature of these interactions and possible additive effects of 
these factors on the risk of violence in schizophrenia.    
 
7.7 Strengths and limitations 
7.7.1 Strengths 
This study included data on a uniquely well-defined sample of men with schizophrenia who 
were drawn from a wide range of in-patient and out-patient mental health services, in order to 
achieve representative sampling across a wide geographical region of England, encompassing 
socially and ethnically diverse populations.  The participants were comprehensively assessed, 
both in terms of their violence and their mental disorders.  The use of the GRVS allowed for the 




This study is limited by its cross-sectional design, which did not allow temporal proximity of the 
measurement of the clinical variables and the violent behaviour.  A prospective methodology will 
allow this type of consideration but will require both a larger sample and repeated assessments 
over time, acknowledging also the relative rarity of incidents of severe violence.  As there were 
no patients in the sample who had CD but no lifetime SUD it was not possible to explore this 






Pre-morbid CD increases the risk of violence in men with schizophrenia, but CD also increases 
the risk of lifetime SUD, which also increases the risk of violence.  Hence both CD and SUD 
play independent roles in the propensity to violence but also interact with each other.  Many 
previous studies of the association between substance misuse and violence in schizophrenia 
have not assessed CD or ASPD; as there is an association between CD and SUD this may 
have led to an over-estimation of the effect of SUD, with a lack of recognition of the independent 
role of CD.  It is clear that prospective longitudinal studies are needed to explore the 
interactions and relationship between CD and early SUD and future violent behaviour.  CD and 
early substance misuse may be fruitful targets for early intervention and treatment in order to 
reduce the risk of later violence among men with schizophrenia.  In addition, treatment 
programmes for adult patients with schizophrenia who have been violent need to address 









This chapter describes exploratory analyses of grey matter abnormalities associated with 
schizophrenia and violence.  There were significant reductions in total grey matter volume and 
evidence of further specific reductions in grey matter volume in the left insula and left superior 
temporal gyrus in patients with schizophrenia compared to healthy controls.  In patients with 
schizophrenia, lifetime propensity to violence was associated with greater grey matter in the left 
caudate, using two analysis methods.  Across all participants, there was a negative correlation 
between psychopathy score and volumes of the left insula and left superior temporal gyrus. 
  
8.2 Background 
8.2.1 Structural imaging studies in schizophrenia 
Schizophrenia is associated with a number of structural brain abnormalities.  However, despite 
decades of research, that began with the earliest post-mortem examinations, to studies using 
the most advanced brain imaging techniques, the nature of these abnormalities, and what they 
tell us about the underlying pathophysiology of the disorder remains poorly understood.  For 
example, there is considerable heterogeneity in the distribution and effect sizes of brain 
differences across studies (Van Erp et al., 2016).  Recent meta-analyses were reviewed to 
obtain an overview of the current knowledge of structural brain abnormalities in schizophrenia.  
 
Meta-analyses have demonstrated grey matter reductions in the insula, thalamus and anterior 
cingulate gyrus (Glahn et al., 2008, Ellison-Wright and Bullmore, 2010, Bora et al., 2011); 
superior temporal gyrus, medial frontal gyrus and amygdala (Bora et al., 2011, Ellison-Wright 
and Bullmore, 2010); hippocampus (Ellison-Wright and Bullmore, 2010) and inferior frontal 
gyrus (Bora et al., 2011).  The largest schizophrenia brain volume meta-analysis conducted to 
date, that included data from over 18,000 subjects, found that patients with schizophrenia have 




matter volume and with focal grey matter reductions (Haijma et al., 2013).  A recent 
collaborative region of interest study of 15 worldwide cohorts of patients with schizophrenia, 
found that patients had smaller hippocampal, amygdalar and thalamic volumes, and larger 
palladial and lateral ventricular volumes (Van Erp et al., 2016).   
  
A meta-analysis of diffusion tensor imaging studies found significant abnormalities in white 
matter in two regions: the first region in the left frontal lobe, has white matter tracts principally 
linking the frontal lobes, thalamus and cingulate gyrus; and the second region in the left 
temporal lobe, has white matter tracts interconnecting the frontal lobe, insula, hippocampus-
amygdala, temporal and occipital lobe (Ellison-Wright and Bullmore, 2009).  This may indicate 
disruption of the white matter tracts that connect grey matter cortical and subcortical structures 
which are known to be abnormal in schizophrenia.  Further reviews report abnormalities in 
multiple white matter regions, including the uncinate fasiculus, fornix, cingulum bundle, arcuate 
fasiculus, anterior commissure and interhemispheric fibres (Fitzsimmons et al., 2013, Yao et al., 
2013, Bora et al., 2011) 
 
Reduced grey matter volume is evident at first presentation of psychosis but further reductions 
are associated with longer duration of illness and higher doses of antipsychotic medication at 
the time of scanning (Haijma et al., 2013).  Progressive volume loss in patients with 
schizophrenia has been demonstrated in longitudinal studies, in both cortical (Vita et al., 2015) 
and subcortical (van Haren et al., 2016) grey matter, but the degree, timing and anatomical 
specificity of any changes remain uncertain.  Male gender and the presence of negative 
symptoms are associated with more extensive grey matter abnormalities, while a longer 
duration of illness is associated with greater grey and white matter deficits (Bora et al., 2011).  
 
The causes of the structural brain abnormalities that have been demonstrated in schizophrenia 
are under investigation, with both genetic and environmental factors being of importance.  Links 
between genetic liability to psychosis and brain abnormalities have been explored in studies of 
individuals at clinical or familial high risk of developing schizophrenia.  Grey and white matter 
abnormalities and differences in the morphology of the cortex have been found in individuals at 




structural abnormalities may be markers of vulnerability to schizophrenia (Bois et al., 2015).  
The role of genetic factors is also demonstrated by the finding that monozygotic twins 
concordant for schizophrenia have reduced thalamic volume compared to discordant twins with 
schizophrenia, whose thalamic volume is also reduced compared to healthy controls (Ettinger et 
al., 2007).  Heritability of more widespread grey matter abnormalities, including in the insula and 
medial frontal and temporal lobes, has been suggested in a study of unaffected siblings (Turner 
et al., 2012).  In addition, specific genes have been linked to structural brain abnormalities, for 
example, alterations in grey matter volume in the prefrontal and temporal regions have been 
associated with disrupted-in-schizophrenia-1 (DISC1) polymorphisms (Trost et al., 2013).   
 
There are also numerous confounding environmental factors which can influence the volume of 
brain structures, including foetal hypoxia, smoking, cannabis use, and nutritional and hydration 
status (Van Erp et al., 2016).  In recent years there has been a focus on the role of 
antipsychotic medication in brain abnormalities in schizophrenia.  Cumulative exposure to 
antipsychotic treatment has been correlated with global loss of grey matter (Fusar-Poli et al., 
2013), with some indication that greater grey matter loss may be associated with first generation 
antipsychotics compared to second generation (Vita et al., 2015).  The association is 
complicated by several factors, including compliance (whether the patient takes the dose that is 
prescribed and hence reported for such studies) and the possibility that patients taking higher 
doses of antipsychotics have a more severe form of the illness.  In addition, relapse duration 
has been associated with significant reductions in both global and regional brain volumes 
(Andreasen et al., 2013).  However, effect sizes for total brain and grey matter volume 
reductions in samples of antipsychotic-naïve first episode of psychosis patients were 
approximately 75% of those in medicated patients, indicating that most of the brain volume 
reduction in schizophrenia is present before treatment is initiated (Haijma et al., 2013).  
Therefore, reduced grey matter is integral to the illness and whilst antipsychotic medication may 
contribute to these deficits it cannot be the sole cause.   
 
8.2.2 Structural imaging studies in schizophrenia and violence 
The literature relating specifically to imaging studies of schizophrenia and violence was 




violence in schizophrenia provide consistent evidence, from both region of interest and whole 
brain studies, of reduced grey matter volume in the hippocampus of patients with schizophrenia 
who are violent compared to those who are not (Barkataki et al., 2006, Yang et al., 2010, 
Kumari et al., 2009a, Kumari et al., 2013).  There is also evidence of grey matter changes in the 
inferior frontal region (Hoptman and Antonius, 2011, Narayan et al., 2007, Schug et al., 2010, 
Hoptman et al., 2014).  Some results are more inconsistent, for example one region of interest 
study found evidence that greater grey matter volume in the orbitofrontal region was associated 
with greater levels of aggression (Hoptman et al., 2005); while another region of interest study 
found reduced grey matter volume in the same region was linked with a history of serious 
violence (Kumari et al., 2009a).  The reason for this inconsistency is not known but it may be of 
relevance that one study measured aggression using the OAS and PANSS, and one study 
considered an act of fatal or near fatal violence towards a victim, and so they were utilizing 
different definitions of aggression/violence.  One region of interest study found an association 
between increased volume of the caudate and aggression (Hoptman et al., 2006) but this region 
has not been identified in whole brain studies of violence and schizophrenia.  One of the most 
relevant confounding factors that may explain some of the variance in these studies is the effect 
of antipsychotic medication (Soyka, 2011).   
 
It is recognised that the application of neuroimaging methods to help understand the origins of 
the link between schizophrenia and violence is in a state of relative infancy, compared to the 
schizophrenia field as a whole, while methodological challenges such as the heterogeneous 
nature of violence and its quantification remain largely unresolved (Hoptman and Antonius, 
2011, Harris et al., 2013).  This study represents one of the first to attempt to address some of 
these methodological challenges more robustly and aimed to deliver preliminary evidence of the 
associations between violence in schizophrenia and cerebral grey matter volume. 
 
8.3 Hypotheses 
Based on the available literature it was hypothesized that patients with schizophrenia, 
compared to healthy controls, will experience reductions in total grey matter volume and in a 




thalamus, medial frontal gyrus, hippocampus, superior temporal gyrus and anterior cingulate 
gyrus. 
 
In patients with schizophrenia, it was hypothesized that those with a greater propensity to 
violence will have reduced grey matter volume in the medial temporal lobe and inferior frontal 
gyrus and greater grey matter volume in the caudate. 
 
8.4 Specific methodology 
All participants were recruited to the study and assessed as described in chapter 4.  Those 
participants who had no medical contraindication for a magnetic resonance imaging (MRI) scan 
and consented, and were able or permitted to travel to the magnetic resonance scanner in 
Northampton (Three Shires Hospital), underwent a structural MRI brain scan. 
 
8.4.1 Data acquisition 
Data were acquired at 1.5T using a Toshiba Excelart Vantage Atlas-X system with actively 
shielded magnetic field gradients and an active shield gradient coil.  A fourteen element Atlas 
SPEEDER head, receive only array coil was used.  T1, T2 and FLAIR structural sequences 
were collected; T2 and FLAIR weighted imaging in the trans-axial plane in conjunction with a T1 
weighted volume scan acquired in the sagittal plane.  The T1-weighted gradient echo sequence 
had the following parameters: repetition time = 12ms; echo time = 5ms; inversion time = 400; 
flip angle = 20°; 120 contiguous 1.1mm sagittal slices; field of view = 28 x 28cm; matrix size = 
256 x 256mm; voxel size = 1.1mm x 1.1mm x 1.1mm. 
 
8.4.2 Data processing 
Data were processed and analysed using SPM8 (Wellcome Trust Centre for Neuroimaging) and 
the voxel-based morphometry VBM8 toolbox (Structural Brain Mapping Group) with default 
parameters.  Voxel based morphometry (VBM) is a neuroimaging analysis technique performed 
on structural MR images to identify the effects of a given variable of interest on brain structure 
and involves spatially normalizing images from all participants in the study (Ashburner and 




experimental groups, using statistical parametric mapping.  VBM can be used to analyse 
differences in brain structure between groups or to identify a relationship in a group between 
brain structure and a given variable, such as a score on a particular task or questionnaire.   
 
A fundamental problem with analysing brain structure across groups is that there may be 
substantial variations in large-scale brain anatomy that are due to natural variability rather than 
the effect of interest.  The VBM method helps to overcome this problem by using a number of 
processes to register the images in the same normalized anatomical space.  The process of 
VBM begins with segmentation; it identifies and separates the scan into one of four tissue types: 
grey matter, white matter, cerebrospinal fluid and other tissues (such as the skull).  Segmented 
images for grey and white matter were summed to estimate total brain volume, which was then 
used as a covariate in the subsequent group analysis stage.  After segmentation, the spatially 
normalized template is created.  This template is then normalized (i.e. shifted and warped) to fit 
the Montreal Neurological Institute (MNI) template.  The images were then smoothed using an 
8mm full-width at half-maximum Gaussian kernel.   
 
8.4.3 Statistical analyses 
Parametric statistical models are assumed at each voxel, using the General Linear Model to 
describe the data in terms of experimental and confounding effects, and residual variability.  
Voxel-wise grey matter differences between patients and healthy controls were examined using 
independent t-tests, controlling for age, alcohol and drug use and total brain volume.   
 
An exploratory whole brain analysis was conducted at an uncorrected threshold of p<0.001.  For 
all significant comparisons, a p value of <0.05, family wise error (FWE) corrected for multiple 
comparison, was then applied.  Reported voxel coordinates were converted from MNI 
coordinates into Talairach coordinates (Lacadie et al., 2008) and Brodmann areas (Yale 
BioImage Suite Package) to confirm their localization in grey matter.  Anatomical descriptions of 
brain regions were obtained using Talairach Deamon (Lancaster et al., 2000).  Results are 





From those clusters in brain regions that differed significantly between the patients and controls, 
we focused on those which previous studies have linked with violence.  Grey matter volumes of 
the identified clusters were extracted and any correlations between grey matter volume and 
both GRVS score and PCL:SV score were estimated using Spearman’s rho rank correlation 
coefficient in SPSS 18.  Finally in the patients only, regression models were constructed in 
SPM8 to identify areas across the whole brain that were predicted by lifetime violence 
propensity as indexed by GRVS score, while controlling for confounding effects of age, whole 




Fifty-five participants underwent a structural MRI brain scan.  One healthy participant was later 
excluded from the analyses due to the new discovery of a space-occupying lesion. They and 
their General Practitioner were advised of this chance finding, for further follow up.  The 
demographic characteristics of the participants who were scanned are shown in table 8-1.   
 
Table 8-1 Demographic characteristics of scanned participants 








32.74 (9.32) 40.43 (8.30) t=-3.14, p=0.003 
IQ 
 
111.00 (14.80) 88.61 (13.72) t=5.67, p<0.001 
Number of CD symptoms 
 
1.00 (1.67) 2.52 (2.83) U=478.50, p=0.022 












0.29 (0.82) 5.96 (5.69) U=638.50, p<0.001 
Gunn Robertson 
Violence Score 
0.61 (0.67) 2.39 (1.37) U=611.00, p<0.001 





The patients’ clinical characteristics are shown in table 8-2.  Scanned patients compared to 
those patients who were not scanned, were older (40.43 vs 32.81 years, p=0.003), and were 
less likely to have misused cannabis (p=0.005).  Fewer patients from secure units were 
scanned (p=0.05), which was due to not having the necessary community leave from the 
Ministry of Justice to travel to the MRI scanner.  Scanned patients did not differ in terms of 
number of lifetime hospital admissions or total time spent in hospital and current dose of 
antipsychotic.  Scanned patients also did not significantly differ from those who were not 
scanned in GRVS score or any of the other clinical variables in table 8-2.  
 
Table 8-2 Clinical demographics of scanned patients (n=23) 








Number of hospital admissions 4.39 (5.19) 
 















Current dose of antipsychotic   
in chlorpromazine equivalent (mg) 
443.96 (289.70) 
Current location (n) 
Community 
Open/locked ward 
Low secure unit 






Mental Health Act status (n) 
Informal 









Forensic section 12 (52%) 
Conduct disorder (n) 8 (35%) 
 
Antisocial personality disorder (n) 8 (35%) 
 
Psychopathy Checklist Screening Version 
score 
5.96 (5.69) 






















Figures are mean and (standard deviation) unless otherwise stated 
 
8.5.2 Differences between patients and controls 
Compared to healthy controls, patients had significantly lower total grey matter and total brain 
volume (see table 8-3). 
 
Table 8-3 Comparison of brain volumes of patients and controls 




















566.04 (55.41) 534.33 (46.31) U=256.00 
p=0.079 





Brain regions where patients had significantly reduced grey matter compared to controls are 
shown in figure 8-1 and table 8-4.  The findings in the left insula and left superior temporal gyrus 
remained statistically significant after FWE correction for multiple comparisons (see figure 8-2).   
 
 
Figure 8-1 Brain regions with reduced grey matter volume in patients compared to controls 
(uncorrected at threshold of p<0.001) 
 
 
Table 8-4 Brain regions where patients had reduced grey matter volume compared to controls 
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32 11 -14  38  7 3.16 0.001 0.996 
Left fusiform 
gyrus 
19 14 -33 -64 -6 3.15 0.001 0.997 




Figure 8-2 Brain regions with reduced grey matter volume in patients compared to controls that 
survived FWE correction 
 
 
Patients had greater grey matter volume in the regions shown in table 8-5 and figure 8-3.  There 
was one artefact where a cluster was not located in grey matter.  None of these regions 









Table 8-5 Brain regions where patients had greater grey matter volume compared to controls 
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21 80 -69 -42  -9 3.40 <0.001 0.952 
Right caudate  
 
 44    4    0  21 3.36 <0.001 0.965 
 
 
Left caudate  
 










11 13 -20  38 -21 3.16 0.001 0.996 
 
 








Figure 8-3 Brain regions with greater grey matter volume in patients compared to controls 
(uncorrected at threshold of p<0.001) 
 
 
8.5.1 Grey matter volume and violence in the patient group 
8.5.1.1 Correlation  
Of the regions which differed significantly in grey matter volume between patients and controls, 
we then focused on the caudate and middle temporal gyrus as they had already been identified 
in the literature as linked to the risk of violence in schizophrenia.  Among the patients, the 
volume in the right middle temporal gyrus was positively correlated with the GRVS at a trend 
level (r= 0.37, p=0.08).  There was no association between volume in the left middle temporal 
gyrus and GRVS. Three cluster peaks were located in the caudate; there was a statistically 
significant positive correlation between the left caudate volume and GRVS score (r=0.50, 
p=0.01; see figure 8-4) and one in the right caudate was positively correlated with GRVS at 
trend level (e, r=0.39, p=0.07).  Caudate volume was not correlated with either duration of 








Figure 8-4 Scatter plot of grey matter volume of the cluster in left caudate (-2 12 4) and GRVS 
score with line of best fit and 95% confidence intervals 
 
8.5.1.2 Regression  
Regression models were constructed in SPM8 to identify areas across the whole brain that 
were predicted by lifetime violence propensity as indexed by GRVS score, while controlling for 
confounding effects of age, whole brain volume and drug and alcohol use.  Those brain regions 
in which GRVS score predicted greater grey matter volume in the patients are shown in figures 
8-5 and 8-6 and table 8-6.  There was a cluster identified in the left caudate, as in the results of 
the correlation described above, however none of these regions remained statistically significant 
after FWE correction.  There was one artefact where a cluster was not located in grey matter.  






Figure 8-5 Brain regions in which GRVS score predicted greater grey matter volume 




Figure 8-6 Regions in which GRVS score predicted greater grey matter volume (uncorrected at 






Table 8-6 Brain regions in which GRVS score predicted greater grey matter volume 
(uncorrected at threshold of p<0.001) 
























114  54  -6  -26 
 
 















3 19  24 -36   76 3.38 <0.001 0.988 
Right 
thalamus 
 11   21 -22   9 3.32 <0.001 0.994 
Left caudate 
 
 17  -4   18   6 3.30 <0.001 0.995 
Right pre 
central gyrus 
6 7  21 -18  81 3.18 0.001 0.999 
*Brodmann area 
 
8.5.2 Psychopathy  
Further post hoc analyses were conducted with the PCL:SV scores and the two brain regions 
which differed significantly between patients and controls after FWE correction (left insula and 
left superior temporal gyrus).  Within the patients only, there was no statistically significant 
correlation between PCL:SV and the volume of grey matter in either region.  However, when 
considering all scanned participants, both the left insula (r= -0.53, p<0.001) and the left superior 
temporal gyrus (r= -0.50, p<0.001) were negatively correlated with PCL:SV score (see figures 8-






Figure 8-7 Scatter plot of grey matter volume of the cluster in the left insula (-45 -1 4) and 





This structural MR brain imaging study found significant reductions in total grey matter volume 
and evidence of further specific reductions in grey matter volume in clusters in the left insula 
and left superior temporal gyrus in patients with schizophrenia compared to healthy controls. 
This was after correcting for multiple comparisons and co-varying for age, alcohol and drug use 
and total brain volume. While other regions, including in the left anterior cingulate and left 
fusiform gyrus, did differ between patients with schizophrenia and controls, these did not survive 






Figure 8-8 Scatter plot of grey matter volume of the left superior temporal gyrus (-46 6 -5) and 
PCL:SV score with line of best fit and 95% confidence intervals 
 
8.6.1.1 Comparison with whole brain studies of schizophrenia 
Grey matter volume reductions, both globally and in specific regions, are a robust finding in 
schizophrenia, supported by individual VBM studies (Nenadic et al., 2015, Gupta et al., 2015) 
and a voxel-wise, coordinate based meta-analysis of VBM studies, that identified that patients 
had reduced grey matter density relative to controls in a network of regions, the largest cluster 
centred on the left insular cortex (BA 13) and also included the STG (BA 22 and 38) (Glahn et 
al., 2008).  Our results of reduced grey matter in the left insula (BA 13) and left STG (BA 22) 
were consistent with this.  Other meta-analyses of VBM studies have also found grey matter 
deficits in the insular cortex and STG in patients with schizophrenia (Ellison-Wright et al., 2008, 





8.6.1.2 Comparison with region of interest studies of schizophrenia 
An early review (Shenton et al., 2001), identified that the majority of imaging studies in 
schizophrenia reported abnormalities in the STG.  The smaller bilateral STG volumes found in 
schizophrenia derive from both the cortical thickness and surface area but not local gyrification, 
and may be particularly marked in the lateral region of the gyrus (Ohi et al., 2016).  In relation to 
the insula, a meta-analysis of region of interest studies of the insula found medium-sized 
reduction of insula volume in schizophrenia, of greatest magnitude in the anterior subregion 
(Shepherd et al., 2012). 
 
Our results support some of our hypotheses, that there would be reduced total grey matter 
volume, with specific reductions in the insula and superior temporal gyrus, among patients with 
schizophrenia.  Whilst our findings are consistent with the previous imaging literature in 
schizophrenia, other hypotheses that there would be reductions in grey matter in other brain 
regions, were not supported by our results.  This particularly relates to not demonstrating 
reduced grey matter of the hippocampus, which is consistently found in both whole brain and 
region of interest studies (Chen et al., 2014, Wright et al., 2000).  Indeed, the largest 
retrospective meta-analysis to date, which examined 38 brain structures, analysed using a 
variety of different methods, found the largest effect size for smaller hippocampal volumes in 
patients versus controls (Haijma et al., 2013).  The largest effect size was also observed for 
smaller hippocampal volumes in a recent region of interest study of subcortical structures in 
more than 2000 patients with schizophrenia (Van Erp et al., 2016). 
 
8.6.2 Violence and schizophrenia 
There was a trend towards a positive correlation between GRVS score and grey matter volume 
of the right middle temporal gyrus.  Greater grey matter volume of a cluster in the left caudate 
was linked with increasing GRVS score, and thus a greater propensity to violence, using two 
analysis methods.  Firstly, a cluster in the left caudate differed significantly between patients 
and controls after correcting for multiple comparisons and then volumes of this cluster among 
patients were positively correlated with GRVS.  Secondly, in the patient group, regression 




after co-varying for age, alcohol and drug use and total brain volume.  Together these results 
support our hypothesis that greater grey matter volume of the caudate is associated with an 
increased propensity to violence.   All the results of the regression analyses were of greater, 
rather than reduced, grey matter being linked with violence but none of these results survived 
stringent FWE correction.   
 
8.6.2.1 Comparison with whole brain studies of violence and schizophrenia 
One previous study reported an association between the right middle temporal gyri and 
aggression in patients with schizophrenia (Lui et al., 2009), however the association was in the 
opposite direction to this current finding, and reported reduced grey matter volume rather than 
increased volume as in this study.  It is not possible to determine the reason for this, and further 
studies will be required to confirm the direction of any association.  However, there are notable 
differences in characteristics between the patients in the two studies, which may contribute to 
the differing findings; the participants in the previous study (Lui et al., 2009) were in their first 
episode of schizophrenia (hence were younger, with a shorter duration of illness), were 
antipsychotic-naïve and the measure of aggression was a current PANSS score rather than 
lifetime propensity to violence.  Therefore, the participants in the two samples had other 
differences between them which are known to affect grey matter volume, and in addition a 
different definition and measure of aggression/violence was utilized in each study.  This may 
limit the ability to compare the results of the two studies.     
 
No whole brain studies were identified in which increased caudate volume was associated with 
violence in schizophrenia. 
 
8.6.2.2 Comparison with region of interest studies of violence and schizophrenia 
One region of interest study of violence and schizophrenia considered the caudate (Hoptman et 
al., 2006); finding that increased volume of the caudate was associated with greater levels of 
aggression measured by OAS and PANSS, after controlling for the effects of age, whole brain 
volume and substance use disorders, as in this study.  The authors point out that long-term 




chronically ill patients) but they did not find a relationship between increased caudate volume 
and duration of illness (Hoptman et al., 2006), although there is no direct measure of exposure 
to antipsychotics so this confounder has not been adequately adjusted for.  Similarly, in the 
current study, there was no correlation between caudate volume and either duration of illness or 
dose of antipsychotic (although this is only current prescription and does not take account of 
length of time of treatment).   
 
No region of interest study of violence and schizophrenia was identified which has examined the 
middle temporal gyri.  The relevant whole brain study is described in section 8.6.2.1 above.   
 
8.6.3 Psychopathy 
Across all scanned participants, there was a negative correlation between PCL:SV score and 
volumes of the left insula and left STG.  This association was not present in the patient group 
only. 
   
8.6.3.1 Comparison with whole brain studies of psychopathy 
A meta-analysis of imaging findings in antisocial, violent and psychopathic individuals found 
reduced prefrontal structure and function in antisocial individuals, which were localized to the 
right orbitofrontal cortex, right anterior cingulate and left dorsolateral prefrontal cortex (Yang and 
Raine, 2009).  A further review suggested that psychopathy specifically may be most associated 
with grey matter volume loss in the amygdala, hippocampus and STG (Dolan, 2010).   A VBM 
study found significant grey matter reductions in the right STG in men with psychopathy (Müller 
et al., 2008).  Indeed it has been suggested that abnormalities in the STG are a key 
discriminator between individuals with psychopathy and healthy controls (Sato et al., 2011).  
This is consistent with our finding that reduced grey matter in the left STG was associated with 
increased PCL:SV score.  
 
Grey matter reductions in the insula have been found in patients with high psychopathy scores, 
and the degree of structural abnormalities were significantly related to the 




some evidence of a functional abnormality of the insula, as offenders with psychopathy have 
been shown to have increased activation in the anterior insula in response to punished errors in 
an event-related probabilistic response reversal task, in contrast to controls, which is thought to 
indicate altered organization of the information-processing system responsible for reinforcement 
learning (Gregory et al., 2015).  The insula is centrally associated with cognitive-affective 
processing and disruption of this processing may have a role in behaviours such as rule-
breaking that are seen in psychopathy (Raine and Yang, 2006).  Therefore there is some 
support in the literature for abnormalities in the insula being associated with psychopathy as has 
been demonstrated in our study.  The abnormalities in the insula and STG are likely to be part 
of a distributed fronto-temporal network of grey matter abnormalities in psychopathy.   
 
8.6.3.2 Comparison with region of interest studies of psychopathy 
A region of interest analysis within a VBM study, revealed no significant differences in the STG 
or anterior insula between participants with ASPD with and without psychopathy (Gregory et al., 
2012).  The majority of region of interest studies in psychopathy have focused on the prefrontal 
cortex and amygdala, due to these regions being considered to be associated with the 
instrumental violence that occurs in psychopathy.  One region of interest study of the amygdala, 
showed that individuals with psychopathy had significant bilateral volume reductions in the 
amygdala compared with healthy controls (Yang et al., 2009).   This finding was not replicated 
in a subsequent VBM study, although it found reduced grey matter volumes in the prefrontal 
cortex (Gregory et al., 2012).  It has been suggested that future region of interest studies in 
psychopathy could usefully focus on regions such as the insula, in addition to the prefrontal 
cortex (Yang and Raine, 2009).  
 
8.6.4 Caudate and violence in schizophrenia 
In this study of men with schizophrenia, lifetime propensity to violence was associated with 
greater grey matter in the left caudate, using two analysis methods.  One previous study in 
patients with schizophrenia found larger caudate volumes were associated with greater levels of 




caudate volume did not differ between healthy controls, participants with ASPD, and patients 
with schizophrenia with and without a history of serious violence (Barkataki et al., 2006). 
 
The caudate is one of the structures that constitute the striatum and has a role in a range of 
motor and non-motor functions, including as part of the reward system.  It has been suggested 
that caudate dysfunction may interfere with the normal functioning of the frontal-subcortical 
circuitry and hence contribute towards aggression (Hoptman et al., 2006).  In addition to 
structural imaging data, there is preliminary evidence from functional imaging that caudate 
dysfunction may contribute to violent behaviour in schizophrenia.  Patients with schizophrenia 
and a history of serious violence showed impaired performance in a response inhibition task 
and reduced activity in the caudate in the condition requiring inhibition (Barkataki et al., 2008).  
The caudate is also implicated in prepulse inhibition of the startle response, which is a measure 
of automatic inhibition and reduced prepulse inhibition has been found to have a modest 
association with violence in schizophrenia (Kumari et al., 2005). 
 
There is also relevant evidence regarding the role of the caudate in violent behaviour in 
individuals with psychopathy.  Greater total grey matter volume has been found in the striatum 
of men with psychopathy and grey matter volume in the caudate head specifically was 
associated with impulsivity and sensation seeking features of psychopathy and caudate body 
volumes were primarily associated with the interpersonal and affective features (Glenn et al., 
2010).  The authors speculated that increased volume of the caudate body may reflect an 
enhanced ability to deceive others and the head of the caudate may be involved in responding 
to rewarding feedback (Glenn et al., 2010).  Compared with non-offenders, violent offenders 
(without schizophrenia) presented with a larger grey matter volume in the right caudate head, 
and these changes were positively correlated with PCL:SV scores and Life History of 
Aggression scores  (Schiffer et al., 2011).  The authors suggested that this may be related to a 
specific deficit among psychopaths in stimulus-reinforcement learning, such that they rely, 
almost exclusively, on reward and fail to take account of punishment (Schiffer et al., 2011).  A 
subsequent study found that among psychopaths compared to healthy controls, there was no 
difference in the volume of the caudate but there were morphological changes which were 





Treatment with both first (Chakos et al., 1994) and second generation (Okugawa et al., 2007) 
antipsychotics has been shown to increase caudate volumes.  It is a potential confounding 
factor that patients who are presenting with violent behaviour may be treated with large doses of 
antipsychotics.  Therefore it may be that caudate volume increase is a consequence of 
antipsychotic drug use rather than being an antecedent of aggression (Hoptman et al., 2006).   
However, clozapine treatment led to caudate volume reduction in three studies, with one study 
demonstrating a 10% volume reduction after one year of taking clozapine (Mouchlianitis et al., 
2016).  It may be of relevance to our findings about violence and the caudate, that clozapine 
has specific anti-aggressive effects in patients with schizophrenia (Frogley et al., 2012).  It is 
possible that caudate dysfunction, whether its origin is pharmacological or otherwise, is of 
relevance in violent behaviour in schizophrenia. Therefore, the caudate may be a focus for 
future imaging studies of violence in schizophrenia, taking account of the additional role of 
psychopathy and antipsychotic treatment as a confounding factor, which was not possible in the 
current study due to sample size.  
 
8.7 Strengths and limitations 
8.7.1 Strengths 
This study included data on a well-defined clinical sample of men with schizophrenia who were 
drawn from a wide range of in-patient and out-patient clinical services.  The participants were 
comprehensively assessed, both in terms of their background history, generally and as it related 
to violence, and their mental disorders.  The presence of the MRI scanner on one of the hospital 
sites where patients were recruited, allowed some restricted patients to be scanned for this 
study, which would not have been possible if the MRI scanner was at a different hospital site.   
 
The use of the GRVS allowed for the objective quantification of the patients’ lifetime propensity 
to violence.  The previous imaging studies of violence in schizophrenia, have utilized a group 
comparison of violent and non-violent participants, which does not account for the heterogeneity 
of violence.  Use of the GRVS has allowed exploration of correlations across a scale of 




Some potential confounders were considered as the analyses controlled for age, total brain 
volume and alcohol and drug use disorders. 
 
8.7.2 Limitations 
Images were acquired on a clinical Toshiba scanner that was not fully optimised for central 
nervous system imaging.  Due to the field of view some participants’ data contained an artefact 
in the lateral temporal lobes, which compromised image quality in that region.  Noise in the data 
led to less than optimal grey/white contrast and prevented a region of interest analysis of small 
medial temporal lobe structures.  As with all VBM studies, the precision of identifying brain 
regions is limited by the precision of the processing steps and for example the later 
transformation from MNI to Talairach coordinates and potential disparity between results.  
 
The relatively modest sample size for this difficult to recruit sample may have resulted in a lack 
of power to detect significant results and a failure to reject a false null hypothesis (type II error).  
In addition, as anticipated the patients had multiple co-morbidities (e.g. antisocial personality 
disorder and substance use disorders), which may have influenced the result, although 
substances use disorders were controlled for in the analysis.  As discussed above, 
antipsychotic use is associated with reductions in total grey matter but also specifically increase 
in caudate volume, and so this may also have contributed to the results.  Although information 
was obtained during data collection about such variables, it was not possible to account for 
them all in the analyses due to the limits of the sample size and statistical power. 
 
8.8 Conclusions 
This chapter describes exploratory analyses of structural brain abnormalities associated with 
schizophrenia and violence.  The primary finding is of greater grey matter of the left caudate 
being associated with increased lifetime propensity to violence.  This is consistent with one 
previous study of individuals with schizophrenia and several of individuals with psychopathy.  
Imaging studies of violence in schizophrenia is a developing area of research and further work 





Chapter 9 Discussion 
9.1 Abstract 
In this chapter the results of the different components of this study are summarized.  They are 
placed in the context of the existing literature and concepts drawn together into a hypothetical 
model of violence in schizophrenia.  Conduct disorder, substance use disorders, childhood 
adversity, schizophrenia and violence are all associated with each other.  Hence there is a 
complex interplay of factors, with their origin in childhood, which increase the risk of violent 
behaviour in schizophrenia.  Future directions for research in the field are suggested. 
 
9.2 Background 
Violence is a complicated behavioural expression that has multiple causes, which may be of 
increased or decreased relevance, both between individuals and at differing times in an 
individual’s lifetime.  It is not achievable to identify a certain factor that causes violence but 
rather that different factors increase the chance that someone will be violent.  The most 
challenging aspect is developing an understanding of the complex interactions between these 
factors, for example whether there is a cumulative effect on violence.  Specifically, in relation to 
schizophrenia, not just the heterogeneous nature of violence itself, but also of psychosis, has 
been a barrier to effective research in the field (Douglas et al., 2009).      
 
9.3 Novelty of study 
9.3.1 Pre-morbid conduct disorder 
It has been suggested that violence among patients with schizophrenia may follow at least two 
distinct pathways, one associated with premorbid conditions, including CD, and another linked 
with the acute psychotic symptoms of schizophrenia (Volavka, 2014, Bo et al., 2011, Volavka 
and Citrome, 2011, Hodgins et al., 2014).  The pathway linked with premorbid conditions is 
associated with higher rates of substance use disorders and higher psychopathy scores in 
adulthood (Tengstrom et al., 2001, Van Dongen et al., 2014); whereas in the other pathway 
violence is primarily linked to positive psychotic symptoms rather than antisocial traits (Van 




understanding of the nature of violence in schizophrenia I chose to differentiate between 
patterns of violent behavior in schizophrenia, and in this study specifically grouped patients on 
the basis of pre-morbid conduct disorder.  This allowed for a more detailed of examination of 
this potential pathway to violence to be conducted.  
 
9.3.2 Quantification of violence 
We first conducted a systematic review relating to the measurement, rating and quantification of 
violent behaviour in mentally disordered populations.  We identified nine tools designed to 
assess violence and critically evaluated them.  Broadly, measurement tools tended to focus on 
multiple, but different, facets of violence, which included: severity of act, severity of outcome, 
frequency and intent, with each suggested as a valid outcome measure for violent acts.  The 
consideration of multiple facets of violence and use of multiple sources of collateral information 
to inform assessment appears to provide detail; however, that detail is then often diluted as a 
result of categorization of sample groups into violent, or aggressive, or not violent, for example.  
Whilst this is beneficial in terms of sample size and study power it does not allow for 
consideration of all the facets of violence, such as severity, outcome and frequency.  Therefore, 
we decided to utilize a scale to measure violence for this study to try to capture some of the 
detail regarding the different facets of violence that is omitted by the use of two or three 
categories and work towards capturing the spectrum of violence.  The GRVS was selected on 
the basis of three primary strengths: firstly, it incorporates data on both criminal justice 
interventions as well as self-reported violent incidents that remain undetected by the police or 
courts; secondly, that it considers severity, frequency and impact of violence; and finally, that it 
is a scale with five categories of violence to allow more detailed grouping of the participants on 
the basis of their violent behaviour.  The use of the GRVS in this study allowed incorporation of 
multiple facets of a person’s propensity to violence into a quantitative summary.   
 
9.4 Limitations 
This study is limited by its cross-sectional design, which does not allow temporal proximity 
between the measurement of the clinical variables and the violent behaviour.  A prospective 




sample and repeated assessments over a long follow-up period, due to the relative rarity of 
incidents of severe violence.   
 
Unfortunately, despite attempting to recruit patients from more NHS Trusts than originally 
planned, the patient sample size did not reach the target of 60 determined by the power 
calculation.  This was due to some difficulties engaging Responsible Clinicians in referring 
potential participants for the research and the reluctance of some of the patients identified to 
take part.  The relatively modest sample size for this difficult to recruit sample may have 
resulted in a lack of power to detect significant results and a failure to reject a false null 
hypothesis (type II error).  This means that potentially clinically significant results were not 
detected as statistically significant due to a lack of power caused by a smaller sample size.  
Although many associations were detected as significant results in this study, the implication of 
a lack of power is that other associations with smaller effect sizes may not have been identified. 
 
9.5 Summary of findings 
9.5.1 Violence, aggressive attitudes and conduct disorder 
This study has demonstrated that the GRVS has good construct validity and reasonable 
concurrent validity.  CD, ASPD and PCL:SV score are all associated with lifetime GRVS after 
controlling for substance use disorders.  Those patients with pre-morbid CD more frequently 
engaged in all types of violent behaviour, apart from choking.  Aggressive attitudes measured 
by the BPAQ, were not associated with violence after relevant adjustments, either in all 
participants or the patient group only.  However, pre-morbid CD was associated with aggressive 
attitudes in adulthood, apart from the hostility sub-scale which was associated with psychotic 
symptoms.  Instrumental violence was associated with higher psychopathy scores.  These 
findings lead to the conclusion that pre-morbid CD is a significant factor determining later 
propensity to violence or a significant marker of that later adult propensity. 
 
9.5.2 Childhood adversity 
In this study of men with schizophrenia, 94% of the most violent patients had experienced at 




associated with violent behaviour in adulthood.  As far as we are aware, this is the first time this 
finding has been demonstrated among individuals with schizophrenia.  The cumulative number 
of childhood adversities was associated with adult propensity to violence and attenuation of this 
association suggested that CD may be a mediator of the relationship.  In other words, that 
childhood adversity via conduct disorder may be a pathway to violent behaviour in 
schizophrenia. 
 
9.5.3 Substance use disorders 
This study has shown that patients with pre-morbid CD had higher rates of lifetime SUD and 
began using alcohol and cannabis earlier and more frequently and used a wider variety of 
drugs.  A lifetime history of SUD was associated with an increased propensity to violence.  A 
trend remained between SUD and violence when we considered only the group of patients who 
did not have pre-morbid CD, emphasising the importance of SUD in violence even in the 
absence of CD.  In addition, CD was associated with an increased propensity to violence, after 
adjusting for SUD.  These findings confirm that both CD and SUD are independently associated 
with an increased risk of violence in schizophrenia.   
 
9.5.4 Structural imaging 
This study found significant reductions in grey matter volume in the left insula and left superior 
temporal gyrus in patients with schizophrenia, compared to controls.  The primary finding 
relating to violence propensity in schizophrenia was an increase in grey matter volume in the 
caudate that was correlated with increased lifetime propensity to violence.  In all scanned 
participants, there was a negative correlation between psychopathy score and volumes of the 
left insula and left superior temporal gyrus.  Caudate abnormalities have previously been 





9.6 Discussion of findings 
The interactions between the variables investigated in this study, on the basis of these results 
and the existing literature, are shown in figure 9-1.  The arrows represent the direction of the 
associations demonstrated but do not imply causality.   
 
Conduct disorder is over-represented in patients with schizophrenia (Kim-Cohen et al., 2003, 
Hodgins et al., 2008) and has been described as a precursor to schizophrenia in some patients, 
with the suggestion that there are specific neurobiological mechanisms underlying this type of 
illness (Schiffer et al., 2013).  As shown in chapter 5, premorbid CD in schizophrenia is 
associated with an increased propensity to lifetime violence, which is in keeping with the 
previous literature (Arseneault et al., 2000, Tengström et al., 2004, Hodgins et al., 2005, 
Swanson et al., 2008). 
 
Childhood adversity increases the risk of CD (Afifi et al., 2011, Foley et al., 2004, Kessler et al., 
1997) and exposure to interpersonal violence in childhood is associated with an increased risk 
of substance abuse (Cerda et al., 2012).  In chapter 6, a cumulative effect of childhood 
adversities on lifetime propensity for violence in schizophrenia was found, which is in keeping 
with another study (Bosqui et al., 2014).  Importantly our study has developed this further by 
suggesting that CD may mediate this association between cumulative childhood adversity and 
violence, which is consistent with a recent study in those with severe mental illness which found 
that childhood onset ASPD mediated the relationship between childhood trauma and recent 
violent acts (Bruce and Laporte, 2015).  A later population survey of young men found that 
witnessing domestic violence in childhood was the childhood adversity most strongly associated 
with violence in adulthood, with psychotic symptoms and ASPD as partial mediators (González 
et al., 2016).  It is possible that exposure to violence within the family home at an early age 













Figure 9-1 Associations between variables under investigation 
 
Co-morbid substance misuse increases the risk of violence in schizophrenia (Swanson et al., 
2006, Elbogen and Johnson, 2009, Fazel et al., 2009).  In chapter 7, I showed that patients with 
schizophrenia and pre-morbid CD began using alcohol and cannabis at an earlier age and with 
greater frequency than those without pre-morbid CD.  This is in line with evidence that among 
patients with a first episode of psychosis, the number of CD symptoms is linked to exposure to 
cannabis at a younger age (Malcolm et al., 2011).  Patients with pre-morbid CD in this study 
also had an increased rate of lifetime SUD, which is supported by results of a previous study 
(Mueser et al., 2006). 
   
Cannabis use increases the risk of subsequent development of psychotic symptoms and 
disorders, with the frequency and quantity of cannabis use influencing the strength of that 
association (Zammit et al., 2002, Arseneault et al., 2004, Di Forti et al., 2015).  Cannabis use in 
early compared to late adolescence is more strongly associated with experiencing symptoms of 
schizophrenia in adulthood (Arseneault et al., 2002).  It may be that CD symptoms 




psychosis (Malcolm et al., 2011).  Childhood adversity is also strongly associated with an 
increased risk for psychosis and could have a significant aetiological role (Varese et al., 2012). 
 
Therefore, as summarized in figure 9-1, CD, SUD, childhood adversity, schizophrenia and 
violence are all associated with each other.  Hence there is a complex interplay of factors, with 
their origin in childhood, which increase the risk of violent behaviour in schizophrenia.  Future 
studies should attempt to dissect the temporality and inter-relationships of these associations.  
 
9.7 Hypothetical pathway to violence in schizophrenia 
Both CD (Blair et al., 2014) and schizophrenia (Murray and Lewis, 1988) are 
neurodevelopmental disorders, where a combination of genetic and environmental factors 
interact to modify the normal trajectory of brain development and behaviour.  From an 
aetiological perspective one possible explanation for why CD is more common among people 
with schizophrenia than the general population, is that a proportion of genetic and 
environmental factors that influence the risk of developing each disorder are common between 
them.   
 
It will be crucial for those attempting to understand the pathway from childhood vulnerability to 
later violence among men with schizophrenia to adopt a developmental lifetime perspective.  
One potential pathway may be that childhood adversity increases the risk of CD, which then 
increases the risk of substance misuse (Malcolm et al., 2011), perhaps earlier than in the 
general population, and at a more critically sensitive point in the brain’s development, which 
then increases the risk of schizophrenia (Di Forti et al., 2015) and behaving violently (Witt et al., 




















Figure 9-2 Hypothetical pathway to violence in schizophrenia 
 
Whilst figure 9-2 conveys some of the potential interplay between factors that may contribute to 
the risk of violence in schizophrenia, questions remain regarding any illness-specific factors that 
are associated with violence.  Various neuropsychological factors have been reported to be 
associated with violence in schizophrenia, most prominently executive dysfunction (Weiss, 
2012, Harris, 2014).  The existing literature on positive psychotic symptoms and associated 
affect, genetics and imaging, and how they may relate to the above model are discussed. 
 
9.7.1 Positive psychotic symptoms 
As discussed in chapter 2, positive psychotic symptoms have been a research focus for the 
drivers of the association between schizophrenia and violence.  There is now an emerging 
literature that explores the importance of the emotional reactions to psychotic symptoms as 
possible drivers of aggressive behaviour in schizophrenia.  Command hallucinations to harm 
others are associated with violence (McNiel et al., 2000) and it has been shown that anger and 













(Bucci et al., 2013).  Distress (van Dongen et al., 2012) or anger (Coid et al., 2013, Ullrich et al., 
2014) due to the delusional belief have been identified as a key factor explaining the link 
between delusions and violence.  Therefore, there are indicators that anger or distress in 
response to positive psychotic symptoms may be important in whether these symptoms are 
associated with violent behaviour.   
 
Whilst psychotic symptoms were not the focus of the current study, understanding these illness-
specific factors will be a crucial component of developing our understanding of the hypothetical 
model outlined above.  It has been suggested that there are at least two distinct pathways to 
violence among patients with schizophrenia, one associated with CD and another with acute 
psychotic symptoms (Volavka, 2014, Bo et al., 2011, Volavka and Citrome, 2011, Hodgins et 
al., 2014).  However, it could be hypothesized that CD and ASPD may increase the likelihood of 
feeling anger in response to positive psychotic symptoms, hence this may be an important 
component of the model.  It would be valuable to consider pre-morbid CD in future studies 
considering emotional responses to psychotic symptoms and the association with violence.  
 
9.7.2 Genetics 
There is an expanding knowledge of the biological correlates of violence in schizophrenia, with 
evidence from meta-analyses of the Met allele of the COMT gene conferring a significantly 
increased risk for violent behaviour in men with schizophrenia (Bhakta et al., 2012, Singh et al., 
2012).  COMT may have a more complex role in this model of violence due to its influence on 
other relevant factors.  There is some evidence that Val carriers of the COMT gene who are 
exposed to childhood trauma are at greater risk of psychotic experiences (Ramsay, 2013) and 
perhaps more vulnerable to the psychosis-inducing effects of cannabis (Alemany et al., 2014).  
Also, in children with attention-deficit hyperactivity disorder, the high-activity COMT genotype is 
associated with antisocial behaviour measured using CD symptoms (Langley et al., 2010).  
Therefore, the COMT gene may have complex interactions with the response to childhood 
adversity, cannabis use, risk of psychotic symptoms and antisocial behaviour.  Hence it may act 






There is consistent evidence of reduced grey matter volume in the hippocampus of patients with 
schizophrenia who are violent compared to those who are not (Barkataki et al., 2006, Yang et 
al., 2010, Kumari et al., 2009a, Kumari et al., 2013).  There is also evidence of grey matter 
changes in the inferior frontal region (Hoptman and Antonius, 2011, Narayan et al., 2007, Schug 
et al., 2010, Hoptman et al., 2014).   Greater grey matter of the caudate predicted increased 
propensity to violence in this study and caudate abnormalities have previously been implicated 
in violence in patients with schizophrenia and with psychopathy (Barkataki et al., 2008, Glenn et 
al., 2010, Boccardi et al., 2013).  It has been suggested that caudate dysfunction may contribute 
towards violence by interfering with the normal functioning of the frontal-subcortical circuitry 
(Hoptman et al., 2006).  Therefore, in the hypothetical model of violence in schizophrenia 
described above, it may be that caudate dysfunction is important for all those with 
schizophrenia, but increasingly so if they have co-morbid psychopathy.  
 
There is increasing evidence in the imaging literature of abnormalities in the amygdala, striatum 
and pre-frontal cortex in ASPD, and also in youths with antisocial behaviour or psychopathic 
traits, giving weight to the argument that ASPD is a neurodevelopmental condition (Raine, 
2018).  Whilst there is emerging evidence regarding the brain regions affected in psychopathy, 
ASPD, schizophrenia and specifically violence in schizophrenia, the complexities of their 
interactions over time, and between co-morbid disorders, will require exploration in future 
studies to elucidate the impact on this model.  
 
9.8 Contributions to knowledge 
There are several key contributions of this study to knowledge in the field.  Firstly, I have 
demonstrated that the GRVS is a valid means of quantifying violence in studies of mental 
disorder.  This can improve the richness of future data by considering different facets of 
violence on a spectrum and enhance the potential for analyses.  The accurate definition and 
measurement of violence has been highlighted as an important methodological challenge in the 
field (Lamsma and Harte, 2015) and I propose that use of the GRVS addresses some of the 





The importance of pre-morbid CD as a determinant of later violent behaviour in schizophrenia 
has been demonstrated throughout this thesis.  Patients with schizophrenia and prior CD had 
an increased propensity to lifetime violence compared to those without a history of CD.  Pre-
morbid CD was also shown to be associated with earlier and more frequent alcohol and 
cannabis use, increased lifetime substance use disorders and cumulative exposure to childhood 
adversities, all of which are themselves associated with violence.   
 
As far as I am aware, this is the first study to demonstrate that exposure to domestic violence in 
childhood is associated with violence in adulthood in men with schizophrenia.  In addition, the 
cumulative number of childhood adversities was associated with adult propensity to violence 
and attenuation of this association suggested that CD may be a mediator of the relationship.  
This potential mediation by CD is an important aspect of further understanding the role of CD in 
violent behaviour in schizophrenia.  
 
The imaging component of this investigation was exploratory in nature and with a smaller 
number of participants than the rest of the study.  Nevertheless, interesting results have 
emerged, particularly in relation to greater grey matter in the caudate being associated with an 
increased propensity to violence.   
 
9.9 Clinical implications 
9.9.1 Assessment 
The findings of this study have important implications for clinicians working with men with 
schizophrenia.  It is crucial for clinicians to understand the importance of pre-morbid CD in 
schizophrenia and the developmental pathway to violence.  In order to assist in determining 
those patients who are at higher risk of behaving violently, it is of paramount importance to 
conduct a thorough assessment of childhood factors when they first present to mental health 
services.  Clinicians should be assessing for pre-morbid CD and taking a careful history of a full 
range of childhood adversities, including exposure to domestic violence.  There should also be 




disorders.  Whilst psychopathy is robustly associated with violence, this is a lengthy assessment 
to undertake which requires specialist training to administer, therefore assessment of pre-
morbid CD is a more practical and hence achievable solution.  In this study, the association with 
violence was present at the level of individual CD symptoms and indicates that it is useful to 
carefully assess these symptoms rather than just the presence of the full disorder.  In summary, 
assessment of patients with schizophrenia should include careful consideration of pre-morbid 
CD symptoms, childhood adversities and substance misuse in adolescence, in order to inform a 
violence risk assessment. 
 
9.9.2 Intervention 
Early use of substances in patients with schizophrenia and pre-morbid CD is important in the 
risk of later violent behaviour.  This emphasises the importance for clinicians of early 
intervention to treat substance abuse and CD with the target of reducing the risk of future 
violence.  Effective treatments are available for CD, particularly parenting training (Weisz et al., 
2004, Scott, 2008).  In addition, there are also well-established treatment programmes for 
adolescent substance use disorders (Hogue et al., 2014).  In adults with schizophrenia and a 
history of violence, it will be crucial to treat any co-morbid substance use disorders as part of 
the risk management plan.   
 
The findings in this study relating to the association between childhood adversities and later 
violent behaviour are important for clinicians but also have wider societal implications.  There is 
a need for the police and social services to respond effectively when children are being exposed 
to domestic violence in the home.  All those who interact with children, including teachers and 
clinicians, have a responsibility to safeguard children from all forms of abuse.  If it was possible 
to intervene earlier and in all cases of childhood abuse, then this would have an impact on 





9.10 Future directions for research 
Despite the global nature of violence, and a wealth of research, its quantification and causes 
still pose a significant research challenge.  Broadly speaking, studies have attempted to quantify 
violence across several different dimensions; however, due to the complex and variable nature 
of violence, and methodological limitations, many of these measures remain largely unvalidated 
across populations.  Data on violent acts are difficult to collect and are often done so 
retrospectively with a reliance on self-report measures.  One of the main difficulties facing 
researchers is the need for large sample sizes in order to validate measures, while still 
preserving the richness of collected data.  Despite this, future studies should move away from 
simply dichotomizing the presence or absence of violence to quantification using multiple 
sources and taking into consideration different dimensions of violence.   
 
This study emphasises the importance of developmental pathways to violence among men with 
schizophrenia.  Understanding the early influences on the complex trajectory towards violence 
in schizophrenia is crucial in order to reduce the risk of future violence.  It is clear that CD 
increases the likelihood of cannabis use in early adolescence, which increases the risk of 
schizophrenia.  Whilst there is an independent increase in the risk of violence associated with 
schizophrenia, pre-morbid CD and lifetime SUD are also associated with increases in the 
propensity to violence.  Future prospective studies would benefit from focusing on the nature of 
these interactions and possible additive effects of these factors on the risk of violence in 
schizophrenia.  In order to achieve this aim, large prospective longitudinal studies of individuals 
in early adolescence, with and without CD, are needed to explore if there is a common 
developmental pathway from childhood adversity, through CD, and drug use to schizophrenia, 
and finally violence.   
 
Whilst a prospective study will be challenging and time consuming to undertake, there is 
learning from this study which can influence future retrospective studies of violence in 
schizophrenia.  This research has contributed to the evidence base showing that pre-morbid CD 
is important in propensity to violence in schizophrenia, therefore future research should ensure 




childhood adversities has been demonstrated, including exposure to domestic violence.  I would 
wish to explore this further in subsequent research, firstly to seek to replicate the finding in 
relation to domestic violence as it has not been demonstrated previously, and secondly to try to 
establish temporality in relation to onset and duration of different childhood adversities and the 
onset of symptoms of CD.  If childhood adversities were the primary focus of a future study, 
then it would be possible to undertake more detailed assessments of this within a duration of 
assessments that is acceptable to participants.  Overall, the key target for future research is that 
more detailed assessment of factors acting in childhood, including substance misuse, CD and 
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